{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T00:50:50Z","timestamp":1794703850493,"version":"4.9.1"},"reference-count":307,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Bone resorption is a vital physiological process that enables skeletal remodeling, maintenance, and adaptation to mechanical forces throughout life. While tightly regulated under the physiological state, its dysregulation contributes to pathological conditions such as osteoporosis, rheumatoid arthritis, and periodontitis. Periodontitis is a highly prevalent chronic inflammatory disease driven by dysbiotic biofilms that disrupt the oral microbiome, leading to the progressive breakdown of the periodontal ligament, cementum, and alveolar bone and ultimately resulting in tooth loss. This review outlines the molecular and cellular mechanisms underlying periodontitis, focusing on osteoclastogenesis, the differentiation and activation of osteoclasts, the primary mediators of bone resorption. Key transcriptional regulators, including NFATc1, c-Fos, and c-Src are discussed alongside major signaling pathways such as Mitogen Activated Protein Kinase (MAPK), Janus Tyrosine Kinase\/Signal Transducer and Activator of Transcription (JAK\/STAT), Nuclear Factor Kappa B (NF-\u03baB), and Phosphoinositide 3-kinase (PI3K)\/Akt, to elucidate their roles in the initiation and progression of periodontal bone loss. These pathways orchestrate the inflammatory response and osteoclast activity, underscoring their relevance in periodontitis and other osteolytic conditions. Hallmark features of periodontitis, including chronic inflammation, immune dysregulation, and tissue destruction are highlighted, with emphasis on current and emerging therapeutic strategies targeting these molecular pathways. Special attention is given to small molecules, biologics, and natural compounds that have the potential to modulate key signaling pathways. Although advances in understanding these mechanisms have identified promising therapeutic targets, translation into effective clinical interventions remains challenging. Continued research into regulating bone-resorptive signaling pathways is essential for developing more effective treatments for periodontitis and related inflammatory bone diseases.<\/jats:p>","DOI":"10.1038\/s41413-025-00478-1","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T09:36:31Z","timestamp":1767432991000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Inflammatory bone loss and signaling pathways in periodontitis: mechanistic insights and emerging therapeutic strategies"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1110-6233","authenticated-orcid":false,"given":"Rafael Scaf","family":"de Molon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1391-320X","authenticated-orcid":false,"given":"Rolando","family":"Vernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela Ezequiel","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6071-553X","authenticated-orcid":false,"given":"Joao Paulo","family":"Steffens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edilson","family":"Ervolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia Helena","family":"Theodoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0301-1966","authenticated-orcid":false,"given":"Jeroen J. J. P.","family":"van den Beucken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Tetradis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"key":"478_CR1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/615486","volume":"2015","author":"SA Hienz","year":"2015","unstructured":"Hienz, S. A., Paliwal, S. & Ivanovski, S. Mechanisms of bone resorption in periodontitis. J. Immunol. Res. 2015, 615486 (2015).","journal-title":"J. Immunol. Res."},{"key":"478_CR2","doi-asserted-by":"publisher","first-page":"633","DOI":"10.32604\/biocell.2022.018031","volume":"46","author":"RS de Molon","year":"2022","unstructured":"de Molon, R. S., de Avila, E. D., Cirelli, J. A. & Steffens, J. P. Periodontal research contributions to basic sciences: from cell communication and host-parasite interactions to inflammation and bone biology. Biocell 46, 633\u2013638 (2022).","journal-title":"Biocell"},{"key":"478_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/jcpe.12935","volume":"45","author":"JG Caton","year":"2018","unstructured":"Caton, J. G. et al. A new classification scheme for periodontal and peri-implant diseases and conditions\u2014introduction and key changes from the 1999 classification. J. Clin. Periodontol. 45, S1\u2013S8 (2018).","journal-title":"J. Clin. Periodontol."},{"key":"478_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nri3785","volume":"15","author":"G Hajishengallis","year":"2015","unstructured":"Hajishengallis, G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat. Rev. Immunol. 15, 30\u201344 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"478_CR5","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41577-020-00488-6","volume":"21","author":"G Hajishengallis","year":"2021","unstructured":"Hajishengallis, G. & Chavakis, T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat. Rev. Immunol. 21, 426\u2013440 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"478_CR6","doi-asserted-by":"publisher","unstructured":"Kinane, D. F., Lappin, D. F. & Culshaw, S. The role of acquired host immunity in periodontal diseases. Periodontol https:\/\/doi.org\/10.1111\/prd.12562 (2024).","DOI":"10.1111\/prd.12562"},{"key":"478_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41368-019-0064-z","volume":"11","author":"W Pan","year":"2019","unstructured":"Pan, W., Wang, Q. & Chen, Q. The cytokine network involved in the host immune response to periodontitis. Int. J. Oral. Sci. 11, 30 (2019).","journal-title":"Int. J. Oral. Sci."},{"key":"478_CR8","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1902\/jop.2012.110676","volume":"83","author":"PI Eke","year":"2012","unstructured":"Eke, P. I., Thornton-Evans, G., Dye, B. & Genco, R. Advances in surveillance of periodontitis: the centers for disease control and prevention periodontal disease surveillance project. J. Periodontol. 83, 1337\u20131342 (2012).","journal-title":"J. Periodontol."},{"key":"478_CR9","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1177\/0022034514552491","volume":"93","author":"NJ Kassebaum","year":"2014","unstructured":"Kassebaum, N. J. et al. Global burden of severe periodontitis in 1990-2010: a systematic review and meta-regression. J. Dent. Res. 93, 1045\u20131053 (2014).","journal-title":"J. Dent. Res"},{"key":"478_CR10","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1902\/jop.2015.140520","volume":"86","author":"PI Eke","year":"2015","unstructured":"Eke, P. I. et al. Update on prevalence of periodontitis in adults in the United States: NHANES 2009 to 2012. J. Periodontol. 86, 611\u2013622 (2015).","journal-title":"J. Periodontol."},{"key":"478_CR11","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1177\/0022034521995157","volume":"100","author":"MG Balta","year":"2021","unstructured":"Balta, M. G., Papathanasiou, E., Blix, I. J. & Van Dyke, T. E. Host modulation and treatment of periodontal disease. J. Dent. Res. 100, 798\u2013809 (2021).","journal-title":"J. Dent. Res."},{"key":"478_CR12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1752-7325.1995.tb02377.x","volume":"55","author":"KR Phipps","year":"1995","unstructured":"Phipps, K. R. & Stevens, V. J. Relative contribution of caries and periodontal disease in adult tooth loss for an HMO dental population. J. Public Health Dent. 55, 250\u2013252 (1995).","journal-title":"J. Public Health Dent."},{"key":"478_CR13","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1177\/0022034515602879","volume":"94","author":"S Listl","year":"2015","unstructured":"Listl, S., Galloway, J., Mossey, P. A. & Marcenes, W. Global economic impact of dental diseases. J. Dent. Res. 94, 1355\u20131361 (2015).","journal-title":"J. Dent. Res."},{"key":"478_CR14","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.4049\/jimmunol.1301970","volume":"192","author":"SG de Aquino","year":"2014","unstructured":"de Aquino, S. G. et al. Periodontal pathogens directly promote autoimmune experimental arthritis by inducing a TLR2- and IL-1-driven Th17 response. J. Immunol. 192, 4103\u20134111 (2014).","journal-title":"J. Immunol."},{"key":"478_CR15","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.3390\/ijms20184541","volume":"20","author":"RS de Molon","year":"2019","unstructured":"de Molon, R. S., Rossa, C., Thurlings, R. M., Cirelli, J. A. & Koenders, M. I. Linkage of periodontitis and rheumatoid arthritis: current evidence and potential biological interactions. Int. J. Mol. Sci 20, 4541 (2019).","journal-title":"Int. J. Mol. Sci"},{"key":"478_CR16","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/jcpe.12743","volume":"44","author":"SG de Aquino","year":"2017","unstructured":"de Aquino, S. G. et al. The aggravation of arthritis by periodontitis is dependent of IL-17 receptor A activation. J. Clin. Periodontol. 44, 881\u2013891 (2017).","journal-title":"J. Clin. Periodontol."},{"key":"478_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/prd.12385","volume":"87","author":"J Gonzalez-Febles","year":"2021","unstructured":"Gonzalez-Febles, J. & Sanz, M. Periodontitis and rheumatoid arthritis: what have we learned about their connection and their treatment? Periodontol 2000 87, 181\u2013203 (2021).","journal-title":"Periodontol 2000"},{"key":"478_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.15415","volume":"27","author":"M Shahbaz","year":"2024","unstructured":"Shahbaz, M. et al. Connecting the dots: NETosis and the periodontitis-rheumatoid arthritis nexus. Int. J. Rheum. Dis. 27, e15415 (2024).","journal-title":"Int. J. Rheum. Dis."},{"key":"478_CR19","doi-asserted-by":"crossref","unstructured":"Belizario, L. C. G. et al. The impact of type 2 diabetes mellitus on non-surgical periodontal treatment: a non-randomized clinical trial. J. Clin. Med. 13, 5978 (2024).","DOI":"10.3390\/jcm13195978"},{"key":"478_CR20","doi-asserted-by":"crossref","unstructured":"de Molon, R. S. et al. The efficacy of topical or systemic antibiotics as adjuvants to non-surgical periodontal treatment in diabetic patients: a systematic review and meta-analysis of randomized clinical trials. J. Clin. Med. 13, 4763 (2024).","DOI":"10.3390\/jcm13164763"},{"key":"478_CR21","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nrendo.2011.106","volume":"7","author":"E Lalla","year":"2011","unstructured":"Lalla, E. & Papapanou, P. N. Diabetes mellitus and periodontitis: a tale of two common interrelated diseases. Nat. Rev. Endocrinol. 7, 738\u2013748 (2011).","journal-title":"Nat. Rev. Endocrinol."},{"key":"478_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-020-01180-w","volume":"20","author":"CZ Wu","year":"2020","unstructured":"Wu, C. Z. et al. Epidemiologic relationship between periodontitis and type 2 diabetes mellitus. BMC Oral. Health 20, 204 (2020).","journal-title":"BMC Oral. Health"},{"key":"478_CR23","doi-asserted-by":"crossref","unstructured":"Rodrigues, J. V. S. et al. The effect of non-surgical periodontal treatment on patients with combined refractory arterial hypertension and stage III, Grade B periodontitis: a preliminary prospective clinical study. J. Clin. Med. 12, 4277 (2023).","DOI":"10.3390\/jcm12134277"},{"key":"478_CR24","doi-asserted-by":"crossref","unstructured":"Rosa, R. A. C. et al. The relationship between hypertension and periodontitis: a cross-sectional study. J. Clin. Med. 12, 5140 (2023).","DOI":"10.3390\/jcm12155140"},{"key":"478_CR25","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.dsx.2019.03.023","volume":"13","author":"AI Khumaedi","year":"2019","unstructured":"Khumaedi, A. I., Purnamasari, D., Wijaya, I. P. & Soeroso, Y. The relationship of diabetes, periodontitis and cardiovascular disease. Diab. Metab. Syndr. 13, 1675\u20131678 (2019).","journal-title":"Diab. Metab. Syndr."},{"key":"478_CR26","doi-asserted-by":"crossref","unstructured":"Liccardo, D. et al. Periodontal disease: a risk factor for diabetes and cardiovascular disease. Int. J. Mol. Sci. 20, 1414 (2019).","DOI":"10.3390\/ijms20061414"},{"key":"478_CR27","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/jcpe.13189","volume":"47","author":"M Sanz","year":"2020","unstructured":"Sanz, M. et al. Periodontitis and cardiovascular diseases: consensus report. J. Clin. Periodontol. 47, 268\u2013288 (2020).","journal-title":"J. Clin. Periodontol."},{"key":"478_CR28","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/s41581-024-00910-5","volume":"21","author":"ILC Chapple","year":"2025","unstructured":"Chapple, I. L. C., Hirschfeld, J., Cockwell, P., Dietrich, T. & Sharma, P. Interplay between periodontitis and chronic kidney disease. Nat. Rev. Nephrol. 21, 226\u2013240 (2025).","journal-title":"Nat. Rev. Nephrol."},{"key":"478_CR29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/prd.12387","volume":"87","author":"R Kuraji","year":"2021","unstructured":"Kuraji, R., Sekino, S., Kapila, Y. & Numabe, Y. Periodontal disease-related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: an emerging concept of oral-liver axis. Periodontol 2000 87, 204\u2013240 (2021).","journal-title":"Periodontol 2000"},{"key":"478_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/prd.12540","volume":"96","author":"G Baima","year":"2024","unstructured":"Baima, G. et al. Periodontitis and risk of cancer: mechanistic evidence. Periodontol 2000 96, 83\u201394 (2024).","journal-title":"Periodontol 2000"},{"key":"478_CR31","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/prd.12590","volume":"96","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y., Meyle, J. & Groeger, S. Periodontal pathogens and cancer development. Periodontol 2000 96, 112\u2013149 (2024).","journal-title":"Periodontol 2000"},{"key":"478_CR32","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1177\/0022034519846113","volume":"98","author":"JD Beck","year":"2019","unstructured":"Beck, J. D., Papapanou, P. N., Philips, K. H. & Offenbacher, S. Periodontal medicine: 100 years of progress. J. Dent. Res. 98, 1053\u20131062 (2019).","journal-title":"J. Dent. Res."},{"key":"478_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fdmed.2023.1144537","volume":"4","author":"LH Theodoro","year":"2023","unstructured":"Theodoro, L. H. et al. Role of junctional epithelium in maintaining dento-gingival adhesion and periodontal health. Front. Dent. Med. 4, 1144537 (2023).","journal-title":"Front. Dent. Med."},{"key":"478_CR34","doi-asserted-by":"publisher","unstructured":"Gomes, N. A. et al. Expression and localization of amelotin, laminin, and protein secreted by follicular dendritic cells after ligature-induced experimental periodontitis in rats. Br. Dent. J. https:\/\/doi.org\/10.1038\/s41415-025-8508-7. (2025).","DOI":"10.1038\/s41415-025-8508-7"},{"key":"478_CR35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/prd.12331","volume":"84","author":"G Hajishengallis","year":"2020","unstructured":"Hajishengallis, G., Chavakis, T. & Lambris, J. D. Current understanding of periodontal disease pathogenesis and targets for host-modulation therapy. Periodontol 2000 84, 14\u201334 (2020).","journal-title":"Periodontol 2000"},{"key":"478_CR36","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2023.2197779","volume":"15","author":"AA Abdulkareem","year":"2023","unstructured":"Abdulkareem, A. A. et al. Current concepts in the pathogenesis of periodontitis: from symbiosis to dysbiosis. J. Oral. Microbiol. 15, 2197779 (2023).","journal-title":"J. Oral. Microbiol."},{"key":"478_CR37","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1600-0757.2006.00166.x","volume":"43","author":"KL Kirkwood","year":"2007","unstructured":"Kirkwood, K. L., Cirelli, J. A., Rogers, J. E. & Giannobile, W. V. Novel host response therapeutic approaches to treat periodontal diseases. Periodontol 2000 43, 294\u2013315 (2007).","journal-title":"Periodontol 2000"},{"key":"478_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2174\/138920009787048347","volume":"10","author":"KL Kirkwood","year":"2009","unstructured":"Kirkwood, K. L. & Rossa, C. Jr The potential of p38 MAPK inhibitors to modulate periodontal infections. Curr. Drug Metab. 10, 55\u201367 (2009).","journal-title":"Curr. Drug Metab."},{"key":"478_CR39","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1590\/S1678-77572012000200002","volume":"20","author":"JA Souza","year":"2012","unstructured":"Souza, J. A., Rossa, C. Jr, Garlet, G. P., Nogueira, A. V. & Cirelli, J. A. Modulation of host cell signaling pathways as a therapeutic approach in periodontal disease. J. Appl. Oral. Sci. 20, 128\u2013138 (2012).","journal-title":"J. Appl. Oral. Sci."},{"key":"478_CR40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","volume":"473","author":"BF Boyce","year":"2008","unstructured":"Boyce, B. F. & Xing, L. Functions of RANKL\/RANK\/OPG in bone modeling and remodeling. Arch. Biochem. Biophys. 473, 139\u2013146 (2008).","journal-title":"Arch. Biochem. Biophys."},{"key":"478_CR41","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.3390\/medicina59101752","volume":"59","author":"D De Leon-Oliva","year":"2023","unstructured":"De Leon-Oliva, D. et al. The RANK-RANKL-OPG system: a multifaceted regulator of homeostasis, immunity, and cancer. Medicina 59, 1752 (2023).","journal-title":"Medicina"},{"key":"478_CR42","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.3390\/biomedicines12102292","volume":"12","author":"G Di Cicco","year":"2024","unstructured":"Di Cicco, G. et al. The pathogenetic role of RANK\/RANKL\/OPG signaling in osteoarthritis and related targeted therapies. Biomedicines 12, 2292 (2024).","journal-title":"Biomedicines"},{"key":"478_CR43","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1590\/1678-775720140259","volume":"23","author":"N Silva","year":"2015","unstructured":"Silva, N. et al. Host response mechanisms in periodontal diseases. J. Appl. Oral. Sci. 23, 329\u2013355 (2015).","journal-title":"J. Appl. Oral. Sci."},{"key":"478_CR44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.it.2013.09.001","volume":"35","author":"G Hajishengallis","year":"2014","unstructured":"Hajishengallis, G. Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends Immunol. 35, 3\u201311 (2014).","journal-title":"Trends Immunol."},{"key":"478_CR45","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/prd.12361","volume":"86","author":"NS Jakubovics","year":"2021","unstructured":"Jakubovics, N. S., Goodman, S. D., Mashburn-Warren, L., Stafford, G. P. & Cieplik, F. The dental plaque biofilm matrix. Periodontol 2000 86, 32\u201356 (2021).","journal-title":"Periodontol 2000"},{"key":"478_CR46","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/0022034510385236","volume":"90","author":"DT Graves","year":"2011","unstructured":"Graves, D. T., Li, J. & Cochran, D. L. Inflammation and uncoupling as mechanisms of periodontal bone loss. J. Dent. Res. 90, 143\u2013153 (2011).","journal-title":"J. Dent. Res."},{"key":"478_CR47","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/9720947","volume":"2023","author":"G Isola","year":"2023","unstructured":"Isola, G. et al. Periodontal health and disease in the context of systemic diseases. Mediators Inflamm. 2023, 9720947 (2023).","journal-title":"Mediators Inflamm."},{"key":"478_CR48","doi-asserted-by":"crossref","unstructured":"Sirisereephap, K. et al. Osteoimmunology in periodontitis: local proteins and compounds to alleviate periodontitis. Int. J. Mol. Sci. 23, 5540 (2022).","DOI":"10.3390\/ijms23105540"},{"key":"478_CR49","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/jre.13326","volume":"60","author":"A Valverde","year":"2025","unstructured":"Valverde, A., George, A., Nares, S. & Naqvi, A. R. Emerging therapeutic strategies targeting bone signaling pathways in periodontitis. J. Periodontal Res. 60, 101\u2013120 (2025).","journal-title":"J. Periodontal Res."},{"key":"478_CR50","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jdsr.2021.09.005","volume":"57","author":"M Usui","year":"2021","unstructured":"Usui, M. et al. Mechanism of alveolar bone destruction in periodontitis\u2014periodontal bacteria and inflammation. Jpn Dent. Sci. Rev. 57, 201\u2013208 (2021).","journal-title":"Jpn Dent. Sci. Rev."},{"key":"478_CR51","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nrmicro2873","volume":"10","author":"G Hajishengallis","year":"2012","unstructured":"Hajishengallis, G., Darveau, R. P. & Curtis, M. A. The keystone-pathogen hypothesis. Nat. Rev. Microbiol. 10, 717\u2013725 (2012).","journal-title":"Nat. Rev. Microbiol."},{"key":"478_CR52","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1902\/annals.2002.7.1.62","volume":"7","author":"DF Kinane","year":"2002","unstructured":"Kinane, D. F. & Lappin, D. F. Immune processes in periodontal disease: a review. Ann. Periodontol. 7, 62\u201371 (2002).","journal-title":"Ann. Periodontol."},{"key":"478_CR53","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1080\/1744666X.2023.2182291","volume":"19","author":"H He","year":"2023","unstructured":"He, H., Hao, Y., Fan, Y., Li, B. & Cheng, L. The interaction between innate immunity and oral microbiota in oral diseases. Expert Rev. Clin. Immunol. 19, 405\u2013415 (2023).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"478_CR54","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s40496-020-00249-3","volume":"7","author":"G Hajishengallis","year":"2020","unstructured":"Hajishengallis, G. & Diaz, P. I. Porphyromonas gingivalis: immune subversion activities and role in periodontal dysbiosis. Curr. Oral. Health Rep. 7, 12\u201321 (2020).","journal-title":"Curr. Oral. Health Rep."},{"key":"478_CR55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/prd.12002","volume":"64","author":"A Cekici","year":"2014","unstructured":"Cekici, A., Kantarci, A., Hasturk, H. & Van Dyke, T. E. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000 64, 57\u201380 (2014).","journal-title":"Periodontol 2000"},{"key":"478_CR56","doi-asserted-by":"crossref","unstructured":"Gu, Y. & Han, X. Toll-like receptor signaling and immune regulatory lymphocytes in periodontal disease. Int. J. Mol. Sci. 21, 3329 (2020).","DOI":"10.3390\/ijms21093329"},{"key":"478_CR57","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos, V. Neutrophil extracellular traps in immunity and disease. Nat. Rev. Immunol. 18, 134\u2013147 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"478_CR58","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1182\/blood-2018-11-844530","volume":"133","author":"FVS Castanheira","year":"2019","unstructured":"Castanheira, F. V. S. & Kubes, P. Neutrophils and NETs in modulating acute and chronic inflammation. Blood 133, 2178\u20132185 (2019).","journal-title":"Blood"},{"key":"478_CR59","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1055\/s-0044-1782211","volume":"18","author":"AO Mousa","year":"2024","unstructured":"Mousa, A. O., Al Hussaini, A. H. A. & Hussein, H. M. The potential role of reactive oxygen species produced by low-density neutrophils in periodontitis. Eur. J. Dent. 18, 1142\u20131148 (2024).","journal-title":"Eur. J. Dent."},{"key":"478_CR60","doi-asserted-by":"crossref","unstructured":"Gysemans, C., Beya, M., Pedace, E. & Mathieu, C. Exploring neutrophil heterogeneity and plasticity in health and disease. Biomedicines 13, 597 (2025).","DOI":"10.3390\/biomedicines13030597"},{"key":"478_CR61","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.it.2017.08.005","volume":"39","author":"NM Moutsopoulos","year":"2018","unstructured":"Moutsopoulos, N. M. & Konkel, J. E. Tissue-specific immunity at the oral mucosal barrier. Trends Immunol. 39, 276\u2013287 (2018).","journal-title":"Trends Immunol."},{"key":"478_CR62","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1902\/jop.2003.74.1.66","volume":"74","author":"A Kantarci","year":"2003","unstructured":"Kantarci, A., Oyaizu, K. & Van Dyke, T. E. Neutrophil-mediated tissue injury in periodontal disease pathogenesis: findings from localized aggressive periodontitis. J. Periodontol. 74, 66\u201375 (2003).","journal-title":"J. Periodontol."},{"key":"478_CR63","doi-asserted-by":"crossref","unstructured":"Dutzan, N. et al. A dysbiotic microbiome triggers T(H)17 cells to mediate oral mucosal immunopathology in mice and humans. Sci. Transl. Med. 10, eaat0797 (2018).","DOI":"10.1126\/scitranslmed.aat0797"},{"key":"478_CR64","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/eji.201344202","volume":"44","author":"G Hajishengallis","year":"2014","unstructured":"Hajishengallis, G. & Lamont, R. J. Breaking bad: manipulation of the host response by Porphyromonas gingivalis. Eur. J. Immunol. 44, 328\u2013338 (2014).","journal-title":"Eur. J. Immunol."},{"key":"478_CR65","doi-asserted-by":"publisher","unstructured":"Chapple, I. L. C., Hirschfeld, J., Kantarci, A., Wilensky, A. & Shapira, L. The role of the host-Neutrophil biology. Periodontol 2000. https:\/\/doi.org\/10.1111\/prd.12490 (2023).","DOI":"10.1111\/prd.12490"},{"key":"478_CR66","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fimmu.2016.00461","volume":"7","author":"MF Konig","year":"2016","unstructured":"Konig, M. F. & Andrade, F. A critical reappraisal of neutrophil extracellular traps and NETosis mimics based on differential requirements for protein citrullination. Front Immunol. 7, 461 (2016).","journal-title":"Front Immunol."},{"key":"478_CR67","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/0022034515609097","volume":"95","author":"PC White","year":"2016","unstructured":"White, P. C., Chicca, I. J., Cooper, P. R., Milward, M. R. & Chapple, I. L. Neutrophil extracellular traps in periodontitis: a web of intrigue. J. Dent. Res. 95, 26\u201334, (2016).","journal-title":"J. Dent. Res."},{"key":"478_CR68","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41590-020-00845-6","volume":"22","author":"M Divangahi","year":"2021","unstructured":"Divangahi, M. et al. Trained immunity, tolerance, priming and differentiation: distinct immunological processes. Nat. Immunol. 22, 2\u20136 (2021).","journal-title":"Nat. Immunol."},{"key":"478_CR69","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/j.cell.2022.03.043","volume":"185","author":"X Li","year":"2022","unstructured":"Li, X. et al. Maladaptive innate immune training of myelopoiesis links inflammatory comorbidities. Cell 185, 1709\u20131727.e1718 (2022).","journal-title":"Cell"},{"key":"478_CR70","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.devcel.2025.02.001","volume":"60","author":"N Haacke","year":"2025","unstructured":"Haacke, N. et al. Innate immune training of osteoclastogenesis promotes inflammatory bone loss in mice. Dev. Cell 60, 1854\u20131870 (2025).","journal-title":"Dev. Cell"},{"key":"478_CR71","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2024.2427234","volume":"15","author":"K Mo","year":"2024","unstructured":"Mo, K., Wang, Y., Lu, C. & Li, Z. Insight into the role of macrophages in periodontitis restoration and development. Virulence 15, 2427234 (2024).","journal-title":"Virulence"},{"key":"478_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.763334","volume":"12","author":"X Sun","year":"2021","unstructured":"Sun, X. et al. Polarized macrophages in periodontitis: characteristics, function, and molecular signaling. Front. Immunol. 12, 763334 (2021).","journal-title":"Front. Immunol."},{"key":"478_CR73","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.job.2022.04.005","volume":"64","author":"V Kini","year":"2022","unstructured":"Kini, V., Mohanty, I., Telang, G. & Vyas, N. Immunopathogenesis and distinct role of Th17 in periodontitis: a review. J. Oral. Biosci. 64, 193\u2013201 (2022).","journal-title":"J. Oral. Biosci."},{"key":"478_CR74","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.3390\/ijms20143394","volume":"20","author":"K Bunte","year":"2019","unstructured":"Bunte, K. & Beikler, T. Th17 Cells and the IL-23\/IL-17 axis in the pathogenesis of periodontitis and immune-mediated inflammatory diseases. Int. J. Mol. Sci. 20, 3394 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"478_CR75","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1177\/154405910808700908","volume":"87","author":"SL Gaffen","year":"2008","unstructured":"Gaffen, S. L. & Hajishengallis, G. A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1\/Th2 paradigm in the context of Th17 cells and IL-17. J. Dent. Res. 87, 817\u2013828 (2008).","journal-title":"J. Dent. Res."},{"key":"478_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.954936","volume":"13","author":"I Rastogi","year":"2022","unstructured":"Rastogi, I. et al. Role of B cells as antigen presenting cells. Front. Immunol. 13, 954936 (2022).","journal-title":"Front. Immunol."},{"key":"478_CR77","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/cei\/uxac090","volume":"210","author":"NM de Gruijter","year":"2022","unstructured":"de Gruijter, N. M., Jebson, B. & Rosser, E. C. Cytokine production by human B cells: role in health and autoimmune disease. Clin. Exp. Immunol. 210, 253\u2013262 (2022).","journal-title":"Clin. Exp. Immunol."},{"key":"478_CR78","first-page":"4283","volume":"11","author":"J Huang","year":"2018","unstructured":"Huang, J., Cai, X., Ou, Y., Zhou, Y. & Wang, Y. Resolution of inflammation in periodontitis: a review. Int. J. Clin. Exp. Pathol. 11, 4283\u20134295 (2018).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"478_CR79","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/prd.12317","volume":"82","author":"TE Van Dyke","year":"2020","unstructured":"Van Dyke, T. E. & Sima, C. Understanding resolution of inflammation in periodontal diseases: Is chronic inflammatory periodontitis a failure to resolve?. Periodontol 2000 82, 205\u2013213 (2020).","journal-title":"Periodontol 2000"},{"key":"478_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108453","volume":"247","author":"EG Eltay","year":"2023","unstructured":"Eltay, E. G. & Van Dyke, T. Resolution of inflammation in oral diseases. Pharm. Ther. 247, 108453 (2023).","journal-title":"Pharm. Ther."},{"key":"478_CR81","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3389\/fimmu.2018.00785","volume":"9","author":"G Mizraji","year":"2018","unstructured":"Mizraji, G., Heyman, O., Van Dyke, T. E. & Wilensky, A. Resolvin D2 restrains Th1 immunity and prevents alveolar bone loss in murine periodontitis. Front. Immunol. 9, 785 (2018).","journal-title":"Front. Immunol."},{"key":"478_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/froh.2023.1288722","volume":"4","author":"V Sahni","year":"2023","unstructured":"Sahni, V. & Van Dyke, T. E. Immunomodulation of periodontitis with SPMs. Front. Oral. Health 4, 1288722 (2023).","journal-title":"Front. Oral. Health"},{"key":"478_CR83","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature13479","volume":"510","author":"CN Serhan","year":"2014","unstructured":"Serhan, C. N. Pro-resolving lipid mediators are leads for resolution physiology. Nature 510, 92\u2013101 (2014).","journal-title":"Nature"},{"key":"478_CR84","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mam.2017.04.006","volume":"58","author":"TE Van Dyke","year":"2017","unstructured":"Van Dyke, T. E. Pro-resolving mediators in the regulation of periodontal disease. Mol. Asp. Med. 58, 21\u201336 (2017).","journal-title":"Mol. Asp. Med."},{"key":"478_CR85","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/prd.12034","volume":"63","author":"MO Freire","year":"2013","unstructured":"Freire, M. O. & Van Dyke, T. E. Natural resolution of inflammation. Periodontol 2000 63, 149\u2013164 (2013).","journal-title":"Periodontol 2000"},{"key":"478_CR86","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s40496-014-0017-8","volume":"1","author":"N Huang","year":"2014","unstructured":"Huang, N. & Gibson, F. C. 3rd. Immuno-pathogenesis of periodontal disease: current and emerging paradigms. Curr. Oral. Health Rep. 1, 124\u2013132 (2014).","journal-title":"Curr. Oral. Health Rep."},{"key":"478_CR87","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/prd.12032","volume":"63","author":"C Sima","year":"2013","unstructured":"Sima, C. & Glogauer, M. Macrophage subsets and osteoimmunology: tuning of the immunological recognition and effector systems that maintain alveolar bone. Periodontol 2000 63, 80\u2013101 (2013).","journal-title":"Periodontol 2000"},{"key":"478_CR88","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/prd.12368","volume":"86","author":"JD Hathaway-Schrader","year":"2021","unstructured":"Hathaway-Schrader, J. D. & Novince, C. M. Maintaining homeostatic control of periodontal bone tissue. Periodontol 2000 86, 157\u2013187 (2021).","journal-title":"Periodontol 2000"},{"key":"478_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1385436","volume":"15","author":"M Zhang","year":"2024","unstructured":"Zhang, M., Liu, Y., Afzali, H. & Graves, D. T. An update on periodontal inflammation and bone loss. Front. Immunol. 15, 1385436 (2024).","journal-title":"Front. Immunol."},{"key":"478_CR90","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3390\/jmp5040033","volume":"5","author":"E Ferrara","year":"2024","unstructured":"Ferrara, E. & Mastrocola, F. Pattern recognition receptors in periodontal disease: molecular mechanisms, signaling pathways, and therapeutic implications. J. Mol. Pathol. 5, 497\u2013511 (2024).","journal-title":"J. Mol. Pathol."},{"key":"478_CR91","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1615\/CritRevEukarGeneExpr.v19.i3.40","volume":"19","author":"E Seeman","year":"2009","unstructured":"Seeman, E. Bone modeling and remodeling. Crit. Rev. Eukaryot. Gene Expr. 19, 219\u2013233 (2009).","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"478_CR92","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.maturitas.2015.07.003","volume":"82","author":"NM Iniguez-Ariza","year":"2015","unstructured":"Iniguez-Ariza, N. M. & Clarke, B. L. Bone biology, signaling pathways, and therapeutic targets for osteoporosis. Maturitas 82, 245\u2013255 (2015).","journal-title":"Maturitas"},{"key":"478_CR93","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41413-022-00219-8","volume":"10","author":"S Bolamperti","year":"2022","unstructured":"Bolamperti, S., Villa, I. & Rubinacci, A. Bone remodeling: an operational process ensuring survival and bone mechanical competence. Bone Res. 10, 48 (2022).","journal-title":"Bone Res."},{"key":"478_CR94","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s12016-015-8523-6","volume":"51","author":"A Sabokbar","year":"2016","unstructured":"Sabokbar, A., Mahoney, D. J., Hemingway, F. & Athanasou, N. A. Non-canonical (RANKL-independent) pathways of osteoclast differentiation and their role in musculoskeletal diseases. Clin. Rev. Allergy Immunol. 51, 16\u201326 (2016).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"478_CR95","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.3390\/cells12212576","volume":"12","author":"V Sromova","year":"2023","unstructured":"Sromova, V., Sobola, D. & Kaspar, P. A brief review of bone cell function and importance. Cells 12, 2576 (2023).","journal-title":"Cells"},{"key":"478_CR96","doi-asserted-by":"publisher","first-page":"e95083","DOI":"10.7554\/eLife.95083","volume":"13","author":"V Daponte","year":"2024","unstructured":"Daponte, V., Henke, K. & Drissi, H. Current perspectives on the multiple roles of osteoclasts: mechanisms of osteoclast-osteoblast communication and potential clinical implications. Elife 13, e95083 (2024).","journal-title":"Elife"},{"key":"478_CR97","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.3390\/cells9092073","volume":"9","author":"JM Kim","year":"2020","unstructured":"Kim, J. M., Lin, C., Stavre, Z., Greenblatt, M. B. & Shim, J. H. Osteoblast-osteoclast communication and bone homeostasis. Cells 9, 2073 (2020).","journal-title":"Cells"},{"key":"478_CR98","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41413-023-00257-w","volume":"11","author":"E Hascoet","year":"2023","unstructured":"Hascoet, E. et al. New insights into inflammatory osteoclast precursors as therapeutic targets for rheumatoid arthritis and periodontitis. Bone Res. 11, 26 (2023).","journal-title":"Bone Res."},{"key":"478_CR99","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41392-023-01467-8","volume":"8","author":"H Xu","year":"2023","unstructured":"Xu, H. et al. Targeting strategies for bone diseases: signaling pathways and clinical studies. Signal Transduct. Target Ther. 8, 202 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"478_CR100","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4248\/BR201301003","volume":"1","author":"X Feng","year":"2013","unstructured":"Feng, X. & Teitelbaum, S. L. Osteoclasts: new insights. Bone Res. 1, 11\u201326 (2013).","journal-title":"Bone Res."},{"key":"478_CR101","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev-pathmechdis-031521-040919","volume":"18","author":"DJ Veis","year":"2023","unstructured":"Veis, D. J. & O\u2019Brien, C. A. Osteoclasts, master sculptors of bone. Annu. Rev. Pathol. 18, 257\u2013281 (2023).","journal-title":"Annu. Rev. Pathol."},{"key":"478_CR102","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41413-022-00205-0","volume":"10","author":"JM Grewe","year":"2022","unstructured":"Grewe, J. M. et al. The role of sphingosine-1-phosphate in bone remodeling and osteoporosis. Bone Res. 10, 34 (2022).","journal-title":"Bone Res."},{"key":"478_CR103","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.semcdb.2020.05.016","volume":"112","author":"K Soe","year":"2021","unstructured":"Soe, K., Delaisse, J. M. & Borggaard, X. G. Osteoclast formation at the bone marrow\/bone surface interface: importance of structural elements, matrix, and intercellular communication. Semin. Cell Dev. Biol. 112, 8\u201315 (2021).","journal-title":"Semin. Cell Dev. Biol."},{"key":"478_CR104","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nature07713","volume":"458","author":"M Ishii","year":"2009","unstructured":"Ishii, M. et al. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature 458, 524\u2013528 (2009).","journal-title":"Nature"},{"key":"478_CR105","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1146\/annurev.immunol.20.100301.064753","volume":"20","author":"LE Theill","year":"2002","unstructured":"Theill, L. E., Boyle, W. J. & Penninger, J. M. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu. Rev. Immunol. 20, 795\u2013823 (2002).","journal-title":"Annu. Rev. Immunol."},{"key":"478_CR106","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/nm.2448","volume":"17","author":"J Xiong","year":"2011","unstructured":"Xiong, J. et al. Matrix-embedded cells control osteoclast formation. Nat. Med. 17, 1235\u20131241 (2011).","journal-title":"Nat. Med."},{"key":"478_CR107","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1084\/jem.20051150","volume":"202","author":"M Asagiri","year":"2005","unstructured":"Asagiri, M. et al. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 202, 1261\u20131269 (2005).","journal-title":"J. Exp. Med."},{"key":"478_CR108","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle, W. J., Simonet, W. S. & Lacey, D. L. Osteoclast differentiation and activation. Nature 423, 337\u2013342 (2003).","journal-title":"Nature"},{"key":"478_CR109","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","volume":"3","author":"H Takayanagi","year":"2002","unstructured":"Takayanagi, H. et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889\u2013901 (2002).","journal-title":"Dev. Cell"},{"key":"478_CR110","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1242\/jcs.108.8.2729","volume":"108","author":"HK Vaananen","year":"1995","unstructured":"Vaananen, H. K. & Horton, M. The osteoclast clear zone is a specialized cell-extracellular matrix adhesion structure. J. Cell Sci. 108, 2729\u20132732 (1995).","journal-title":"J. Cell Sci."},{"key":"478_CR111","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1126\/science.276.5310.266","volume":"276","author":"SA Nesbitt","year":"1997","unstructured":"Nesbitt, S. A. & Horton, M. A. Trafficking of matrix collagens through bone-resorbing osteoclasts. Science 276, 266\u2013269 (1997).","journal-title":"Science"},{"key":"478_CR112","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s12276-024-01157-7","volume":"56","author":"N Takegahara","year":"2024","unstructured":"Takegahara, N., Kim, H. & Choi, Y. Unraveling the intricacies of osteoclast differentiation and maturation: insight into novel therapeutic strategies for bone-destructive diseases. Exp. Mol. Med. 56, 264\u2013272 (2024).","journal-title":"Exp. Mol. Med."},{"key":"478_CR113","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1242\/jcs.113.3.377","volume":"113","author":"HK Vaananen","year":"2000","unstructured":"Vaananen, H. K., Zhao, H., Mulari, M. & Halleen, J. M. The cell biology of osteoclast function. J. Cell Sci. 113, 377\u2013381 (2000).","journal-title":"J. Cell Sci."},{"key":"478_CR114","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/S0889-8553(21)00448-9","volume":"18","author":"JA Ajani","year":"1989","unstructured":"Ajani, J. A., Levin, B. & Wallace, S. Systemic and regional therapy of advanced islet cell tumors. Gastroenterol. Clin. North Am. 18, 923\u2013930 (1989).","journal-title":"Gastroenterol. Clin. North Am."},{"key":"478_CR115","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1517\/13543784.9.6.1281","volume":"9","author":"GD Hartman","year":"2000","unstructured":"Hartman, G. D. & Duggan, M. E. alpha(v)beta(3) Integrin antagonists as inhibitors of bone resorption. Expert Opin. Investig. Drugs 9, 1281\u20131291 (2000).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"478_CR116","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.3390\/ijms22094321","volume":"22","author":"A Guasto","year":"2021","unstructured":"Guasto, A. & Cormier-Daire, V. Signaling pathways in bone development and their related skeletal dysplasia. Int. J. Mol. Sci 22, 4321 (2021).","journal-title":"Int. J. Mol. Sci"},{"key":"478_CR117","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.abb.2014.05.003","volume":"561","author":"M Capulli","year":"2014","unstructured":"Capulli, M., Paone, R. & Rucci, N. Osteoblast and osteocyte: games without frontiers. Arch. Biochem. Biophys. 561, 3\u201312 (2014).","journal-title":"Arch. Biochem. Biophys."},{"key":"478_CR118","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.abb.2008.03.027","volume":"473","author":"K Matsuo","year":"2008","unstructured":"Matsuo, K. & Irie, N. Osteoclast-osteoblast communication. Arch. Biochem. Biophys. 473, 201\u2013209 (2008).","journal-title":"Arch. Biochem. Biophys."},{"key":"478_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1357-2725(03)00241-3","volume":"36","author":"ML Knothe Tate","year":"2004","unstructured":"Knothe Tate, M. L., Adamson, J. R., Tami, A. E. & Bauer, T. W. The osteocyte. Int. J. Biochem. Cell Biol. 36, 1\u20138 (2004).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"478_CR120","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/jbmr.320","volume":"26","author":"LF Bonewald","year":"2011","unstructured":"Bonewald, L. F. The amazing osteocyte. J. Bone Miner. Res. 26, 229\u2013238 (2011).","journal-title":"J. Bone Miner. Res."},{"key":"478_CR121","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.cell.2021.02.002","volume":"184","author":"MM McDonald","year":"2021","unstructured":"McDonald, M. M. et al. Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption. Cell 184, 1330\u20131347.e1313 (2021).","journal-title":"Cell"},{"key":"478_CR122","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1002\/jbmr.3091","volume":"32","author":"NE Lassen","year":"2017","unstructured":"Lassen, N. E. et al. Coupling of bone resorption and formation in real time: new knowledge gained from human Haversian BMUs. J. Bone Miner. Res. 32, 1395\u20131405 (2017).","journal-title":"J. Bone Miner. Res."},{"key":"478_CR123","doi-asserted-by":"publisher","first-page":"175","DOI":"10.4103\/2230-8210.83401","volume":"15","author":"SS Kohli","year":"2011","unstructured":"Kohli, S. S. & Kohli, V. S. Role of RANKL-RANK\/osteoprotegerin molecular complex in bone remodeling and its immunopathologic implications. Indian J. Endocrinol. Metab. 15, 175\u2013181 (2011).","journal-title":"Indian J. Endocrinol. Metab."},{"key":"478_CR124","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3389\/fimmu.2014.00511","volume":"5","author":"MC Walsh","year":"2014","unstructured":"Walsh, M. C. & Choi, Y. Biology of the RANKL-RANK-OPG system in immunity, bone, and beyond. Front. Immunol. 5, 511 (2014).","journal-title":"Front. Immunol."},{"key":"478_CR125","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s41232-019-0111-3","volume":"40","author":"T Ono","year":"2020","unstructured":"Ono, T., Hayashi, M., Sasaki, F. & Nakashima, T. RANKL biology: bone metabolism, the immune system, and beyond. Inflamm. Regen. 40, 2 (2020).","journal-title":"Inflamm. Regen."},{"key":"478_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2022.116353","volume":"159","author":"N Takegahara","year":"2022","unstructured":"Takegahara, N., Kim, H. & Choi, Y. RANKL biology. Bone 159, 116353 (2022).","journal-title":"Bone"},{"key":"478_CR127","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.intimp.2016.04.024","volume":"36","author":"J An","year":"2016","unstructured":"An, J. et al. Natural products for treatment of bone erosive diseases: the effects and mechanisms on inhibiting osteoclastogenesis and bone resorption. Int. Immunopharmacol. 36, 118\u2013131 (2016).","journal-title":"Int. Immunopharmacol."},{"key":"478_CR128","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.job.2020.02.002","volume":"62","author":"MS AlQranei","year":"2020","unstructured":"AlQranei, M. S. & Chellaiah, M. A. Osteoclastogenesis in periodontal diseases: Possible mediators and mechanisms. J. Oral. Biosci. 62, 123\u2013130 (2020).","journal-title":"J. Oral. Biosci."},{"key":"478_CR129","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/16852","volume":"397","author":"YY Kong","year":"1999","unstructured":"Kong, Y. Y. et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315\u2013323 (1999).","journal-title":"Nature"},{"key":"478_CR130","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","volume":"13","author":"WC Dougall","year":"1999","unstructured":"Dougall, W. C. et al. RANK is essential for osteoclast and lymph node development. Genes Dev. 13, 2412\u20132424 (1999).","journal-title":"Genes Dev."},{"key":"478_CR131","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1006\/bbrc.1998.8697","volume":"247","author":"A Mizuno","year":"1998","unstructured":"Mizuno, A. et al. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor\/osteoprotegerin. Biochem. Biophys. Res. Commun. 247, 610\u2013615 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"478_CR132","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"WS Simonet","year":"1997","unstructured":"Simonet, W. S. et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89, 309\u2013319 (1997).","journal-title":"Cell"},{"key":"478_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108881","volume":"108","author":"S Ni","year":"2022","unstructured":"Ni, S., Shan, F. & Geng, J. Interleukin-10 family members: Biology and role in the bone and joint diseases. Int. Immunopharmacol. 108, 108881 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"478_CR134","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/ar3379","volume":"13","author":"B Zhao","year":"2011","unstructured":"Zhao, B. & Ivashkiv, L. B. Negative regulation of osteoclastogenesis and bone resorption by cytokines and transcriptional repressors. Arthritis Res. Ther. 13, 234 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"478_CR135","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/cells11010132","volume":"11","author":"Z Yao","year":"2021","unstructured":"Yao, Z., Getting, S. J. & Locke, I. C. Regulation of TNF-induced osteoclast differentiation. Cells 11, 132 (2021).","journal-title":"Cells"},{"key":"478_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2022.116540","volume":"164","author":"P Zhou","year":"2022","unstructured":"Zhou, P., Zheng, T. & Zhao, B. Cytokine-mediated immunomodulation of osteoclastogenesis. Bone 164, 116540 (2022).","journal-title":"Bone"},{"key":"478_CR137","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","volume":"8","author":"S Chen","year":"2023","unstructured":"Chen, S. et al. Macrophages in immunoregulation and therapeutics. Signal Transduct. Target Ther. 8, 207 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"478_CR138","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1177\/0022034518777973","volume":"97","author":"A Viniegra","year":"2018","unstructured":"Viniegra, A. et al. Resolving macrophages counter osteolysis by anabolic actions on bone cells. J. Dent. Res. 97, 1160\u20131169 (2018).","journal-title":"J. Dent. Res."},{"key":"478_CR139","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.4049\/jimmunol.173.4.2571","volume":"173","author":"YN Lee","year":"2004","unstructured":"Lee, Y. N. et al. c-Fos as a regulator of degranulation and cytokine production in FcepsilonRI-activated mast cells. J. Immunol. 173, 2571\u20132577 (2004).","journal-title":"J. Immunol."},{"key":"478_CR140","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1083\/jcb.201002111","volume":"190","author":"A Bozec","year":"2010","unstructured":"Bozec, A. et al. Fra-2\/AP-1 controls bone formation by regulating osteoblast differentiation and collagen production. J. Cell Biol. 190, 1093\u20131106 (2010).","journal-title":"J. Cell Biol."},{"key":"478_CR141","doi-asserted-by":"publisher","first-page":"31046","DOI":"10.1074\/jbc.M702833200","volume":"282","author":"CE Malnou","year":"2007","unstructured":"Malnou, C. E. et al. Heterodimerization with Jun family members regulates c-Fos nucleocytoplasmic traffic. J. Biol. Chem. 282, 31046\u201331059 (2007).","journal-title":"J. Biol. Chem."},{"key":"478_CR142","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/72855","volume":"24","author":"K Matsuo","year":"2000","unstructured":"Matsuo, K. et al. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat. Genet. 24, 184\u2013187 (2000).","journal-title":"Nat. Genet."},{"key":"478_CR143","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/360741a0","volume":"360","author":"ZQ Wang","year":"1992","unstructured":"Wang, Z. Q. et al. Bone and haematopoietic defects in mice lacking c-fos. Nature 360, 741\u2013745 (1992).","journal-title":"Nature"},{"key":"478_CR144","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1126\/science.7939685","volume":"266","author":"AE Grigoriadis","year":"1994","unstructured":"Grigoriadis, A. E. et al. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266, 443\u2013448 (1994).","journal-title":"Science"},{"key":"478_CR145","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1111\/jcmm.14948","volume":"24","author":"MA Al Mamun","year":"2020","unstructured":"Al Mamun, M. A., Asim, M. M. H., Sahin, M. A. Z. & Al-Bari, M. A. A. Flavonoids compounds from Tridax procumbens inhibit osteoclast differentiation by down-regulating c-Fos activation. J. Cell Mol. Med. 24, 2542\u20132551, (2020).","journal-title":"J. Cell Mol. Med."},{"key":"478_CR146","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/jbmr.1576","volume":"27","author":"X Wu","year":"2012","unstructured":"Wu, X. et al. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-kappaB ligand-induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase\/activator protein 1 and Ca2+-nuclear factor of activated T-cells cytoplasmic 1 signaling pathways. J. Bone Miner. Res. 27, 1298\u20131308 (2012).","journal-title":"J. Bone Miner. Res."},{"key":"478_CR147","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.joen.2007.07.034","volume":"34","author":"J Yang","year":"2008","unstructured":"Yang, J. & Peng, B. Correlation between the expression of c-Fos and osteoclasts in induced periapical lesions in rats. J. Endod. 34, 22\u201325 (2008).","journal-title":"J. Endod."},{"key":"478_CR148","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1002\/jcp.29207","volume":"235","author":"W Xu","year":"2020","unstructured":"Xu, W. et al. Chitooligosaccharide inhibits RANKL-induced osteoclastogenesis and ligation-induced periodontitis by suppressing MAPK\/ c-fos\/NFATC1 signaling. J. Cell Physiol. 235, 3022\u20133032 (2020).","journal-title":"J. Cell Physiol."},{"key":"478_CR149","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/intimm\/dxl004","volume":"18","author":"N Ray","year":"2006","unstructured":"Ray, N. et al. c-Fos suppresses systemic inflammatory response to endotoxin. Int. Immunol. 18, 671\u2013677 (2006).","journal-title":"Int. Immunol."},{"key":"478_CR150","doi-asserted-by":"publisher","first-page":"8682","DOI":"10.3390\/ijms24108682","volume":"24","author":"Z Zhang","year":"2023","unstructured":"Zhang, Z. et al. Pirfenidone inhibits alveolar bone loss in ligature-induced periodontitis by suppressing the NF-kappaB signaling pathway in mice. Int. J. Mol. Sci. 24, 8682 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"478_CR151","doi-asserted-by":"publisher","first-page":"16175","DOI":"10.3390\/ijms242216175","volume":"24","author":"T Jiang","year":"2023","unstructured":"Jiang, T. et al. Role and regulation of transcription factors in osteoclastogenesis. Int. J. Mol. Sci. 24, 16175 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"478_CR152","doi-asserted-by":"publisher","first-page":"233","DOI":"10.11005\/jbm.2014.21.4.233","volume":"21","author":"JH Kim","year":"2014","unstructured":"Kim, J. H. & Kim, N. Regulation of NFATc1 in osteoclast differentiation. J. Bone Metab. 21, 233\u2013241 (2014).","journal-title":"J. Bone Metab."},{"key":"478_CR153","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.2741\/2252","volume":"12","author":"Q Zhao","year":"2007","unstructured":"Zhao, Q., Shao, J., Chen, W. & Li, Y. P. Osteoclast differentiation and gene regulation. Front. Biosci. 12, 2519\u20132529 (2007).","journal-title":"Front. Biosci."},{"key":"478_CR154","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-1-4419-1050-9_8","volume":"658","author":"AO Aliprantis","year":"2010","unstructured":"Aliprantis, A. O. & Glimcher, L. H. NFATc1 in inflammatory and musculoskeletal conditions. Adv. Exp. Med. Biol. 658, 69\u201375 (2010).","journal-title":"Adv. Exp. Med. Biol."},{"key":"478_CR155","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.biocel.2009.12.018","volume":"42","author":"Q Zhao","year":"2010","unstructured":"Zhao, Q., Wang, X., Liu, Y., He, A. & Jia, R. NFATc1: functions in osteoclasts. Int. J. Biochem. Cell Biol. 42, 576\u2013579 (2010).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"478_CR156","doi-asserted-by":"publisher","first-page":"19914","DOI":"10.1073\/pnas.1320036110","volume":"110","author":"MB Greenblatt","year":"2013","unstructured":"Greenblatt, M. B. et al. NFATc1 and NFATc2 repress spontaneous osteoarthritis. Proc. Natl. Acad. Sci. USA 110, 19914\u201319919 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"478_CR157","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0092-8674(00)80222-6","volume":"89","author":"H Zhong","year":"1997","unstructured":"Zhong, H., SuYang, H., Erdjument-Bromage, H., Tempst, P. & Ghosh, S. The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89, 413\u2013424 (1997).","journal-title":"Cell"},{"key":"478_CR158","doi-asserted-by":"publisher","first-page":"18245","DOI":"10.1074\/jbc.M610701200","volume":"282","author":"T Yamashita","year":"2007","unstructured":"Yamashita, T. et al. NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1. J. Biol. Chem. 282, 18245\u201318253 (2007).","journal-title":"J. Biol. Chem."},{"key":"478_CR159","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3109\/08820139.2013.822766","volume":"42","author":"PP Souza","year":"2013","unstructured":"Souza, P. P. & Lerner, U. H. The role of cytokines in inflammatory bone loss. Immunol. Investig. 42, 555\u2013622 (2013).","journal-title":"Immunol. Investig."},{"key":"478_CR160","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1365-2591.2009.01649.x","volume":"43","author":"C Zhang","year":"2010","unstructured":"Zhang, C., Yang, L. & Peng, B. Critical role of NFATc1 in periapical lesions. Int. Endod. J. 43, 109\u2013114 (2010).","journal-title":"Int. Endod. J."},{"key":"478_CR161","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.taap.2018.06.017","volume":"355","author":"HJ Ihn","year":"2018","unstructured":"Ihn, H. J. et al. A novel benzamide derivative protects ligature-induced alveolar bone erosion by inhibiting NFATc1-mediated osteoclastogenesis. Toxicol. Appl. Pharm. 355, 9\u201317 (2018).","journal-title":"Toxicol. Appl. Pharm."},{"key":"478_CR162","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/jbmr.4478","volume":"37","author":"HJ Kim","year":"2022","unstructured":"Kim, H. J. et al. Myeloid-specific PTP1B deficiency attenuates inflammation-induced and ovariectomy-induced bone loss in mice by inhibiting osteoclastogenesis. J. Bone Miner. Res. 37, 505\u2013514 (2022).","journal-title":"J. Bone Miner. Res."},{"key":"478_CR163","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1177\/00220345211027811","volume":"101","author":"N Da Ponte Leguizamon","year":"2022","unstructured":"Da Ponte Leguizamon, N. et al. Phytocystatin CsinCPI-2 reduces osteoclastogenesis and alveolar bone loss. J. Dent. Res. 101, 216\u2013225 (2022).","journal-title":"J. Dent. Res."},{"key":"478_CR164","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2302\/kjm.60.101","volume":"60","author":"T Miyamoto","year":"2011","unstructured":"Miyamoto, T. Regulators of osteoclast differentiation and cell-cell fusion. Keio J. Med. 60, 101\u2013105 (2011).","journal-title":"Keio J. Med."},{"key":"478_CR165","doi-asserted-by":"publisher","first-page":"5508","DOI":"10.3390\/ijms23105508","volume":"23","author":"T Matsubara","year":"2022","unstructured":"Matsubara, T., Yasuda, K., Mizuta, K., Kawaue, H. & Kokabu, S. Tyrosine kinase Src is a regulatory factor of bone homeostasis. Int. J. Mol. Sci. 23, 5508 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"478_CR166","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1258740","volume":"15","author":"R Chen","year":"2024","unstructured":"Chen, R. et al. Roles of ubiquitin-specific proteases in inflammatory diseases. Front. Immunol. 15, 1258740 (2024).","journal-title":"Front. Immunol."},{"key":"478_CR167","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1172\/JCI119679","volume":"100","author":"Y Abu-Amer","year":"1997","unstructured":"Abu-Amer, Y., Ross, F. P., Edwards, J. & Teitelbaum, S. L. Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. J. Clin. Invest. 100, 1557\u20131565 (1997).","journal-title":"J. Clin. Invest."},{"key":"478_CR168","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/iej.14057","volume":"57","author":"HQ Mao","year":"2024","unstructured":"Mao, H. Q. et al. STING inhibition alleviates bone resorption in apical periodontitis. Int. Endod. J. 57, 951\u2013965 (2024).","journal-title":"Int. Endod. J."},{"key":"478_CR169","doi-asserted-by":"crossref","unstructured":"Kleinert, H., Art, J. & Pautz, A. in Nitric Oxide (Second Edition) 211\u2013267 (2010).","DOI":"10.1016\/B978-0-12-373866-0.00007-1"},{"key":"478_CR170","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.2174\/1381612043382936","volume":"10","author":"A Piiper","year":"2004","unstructured":"Piiper, A. & Zeuzem, S. Receptor tyrosine kinases are signaling intermediates of G protein-coupled receptors. Curr. Pharm. Des. 10, 3539\u20133545 (2004).","journal-title":"Curr. Pharm. Des."},{"key":"478_CR171","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1902\/jop.2005.76.7.1148","volume":"76","author":"R Ambili","year":"2005","unstructured":"Ambili, R., Santhi, W. S., Janam, P., Nandakumar, K. & Pillai, M. R. Expression of activated transcription factor nuclear factor-kappaB in periodontally diseased tissues. J. Periodontol. 76, 1148\u20131153 (2005).","journal-title":"J. Periodontol."},{"key":"478_CR172","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.lfs.2009.03.001","volume":"84","author":"S Garcia de Aquino","year":"2009","unstructured":"Garcia de Aquino, S. et al. Signaling pathways associated with the expression of inflammatory mediators activated during the course of two models of experimental periodontitis. Life Sci. 84, 745\u2013754 (2009).","journal-title":"Life Sci."},{"key":"478_CR173","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.smim.2014.05.004","volume":"26","author":"MS Hayden","year":"2014","unstructured":"Hayden, M. S. & Ghosh, S. Regulation of NF-kappaB by TNF family cytokines. Semin Immunol. 26, 253\u2013266 (2014).","journal-title":"Semin Immunol."},{"key":"478_CR174","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/embr.201337983","volume":"15","author":"M Hinz","year":"2014","unstructured":"Hinz, M. & Scheidereit, C. The IkappaB kinase complex in NF-kappaB regulation and beyond. EMBO Rep. 15, 46\u201361 (2014).","journal-title":"EMBO Rep."},{"key":"478_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.biosystems.2021.104564","volume":"211","author":"K Trares","year":"2022","unstructured":"Trares, K., Ackermann, J. & Koch, I. The canonical and non-canonical NF-kappaB pathways and their crosstalk: a comparative study based on Petri nets. Biosystems 211, 104564 (2022).","journal-title":"Biosystems"},{"key":"478_CR176","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri.2017.52","volume":"17","author":"SC Sun","year":"2017","unstructured":"Sun, S. C. The non-canonical NF-kappaB pathway in immunity and inflammation. Nat. Rev. Immunol. 17, 545\u2013558 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"478_CR177","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101077","volume":"297","author":"NA Snyder","year":"2021","unstructured":"Snyder, N. A. & Silva, G. M. Deubiquitinating enzymes (DUBs): regulation, homeostasis, and oxidative stress response. J. Biol. Chem. 297, 101077 (2021).","journal-title":"J. Biol. Chem."},{"key":"478_CR178","doi-asserted-by":"publisher","first-page":"192","DOI":"10.18632\/aging.100296","volume":"3","author":"LS Steelman","year":"2011","unstructured":"Steelman, L. S. et al. Roles of the Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging 3, 192\u2013222 (2011).","journal-title":"Aging"},{"key":"478_CR179","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo, Q. et al. NF-kappaB in biology and targeted therapy: new insights and translational implications. Signal Transduct. Target Ther. 9, 53 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"478_CR180","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3803\/EnM.2023.501","volume":"38","author":"BF Boyce","year":"2023","unstructured":"Boyce, B. F., Li, J., Yao, Z. & Xing, L. Nuclear factor-kappa B regulation of osteoclastogenesis and osteoblastogenesis. Endocrinol. Metab. 38, 504\u2013521 (2023).","journal-title":"Endocrinol. Metab."},{"key":"478_CR181","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/ar300","volume":"3","author":"SS Makarov","year":"2001","unstructured":"Makarov, S. S. & NF-kappa, B. in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction. Arthritis Res. 3, 200\u2013206 (2001).","journal-title":"Arthritis Res."},{"key":"478_CR182","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.phrs.2016.07.038","volume":"111","author":"R Roskoski Jr","year":"2016","unstructured":"Roskoski, R. Jr Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases. Pharm. Res. 111, 784\u2013803 (2016).","journal-title":"Pharm. Res."},{"key":"478_CR183","doi-asserted-by":"publisher","DOI":"10.1590\/1678-7757-2022-0316","volume":"30","author":"X Chen","year":"2022","unstructured":"Chen, X. et al. Macrophage M1 polarization mediated via the IL-6\/STAT3 pathway contributes to apical periodontitis induced by Porphyromonas gingivalis. J. Appl. Oral. Sci. 30, e20220316 (2022).","journal-title":"J. Appl. Oral. Sci."},{"key":"478_CR184","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1177\/00220345231192381","volume":"102","author":"M Arce","year":"2023","unstructured":"Arce, M. et al. Increased STAT3 activation in periodontitis drives inflammatory bone loss. J. Dent. Res. 102, 1366\u20131375 (2023).","journal-title":"J. Dent. Res."},{"key":"478_CR185","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/650812","volume":"2013","author":"JA Chaves de Souza","year":"2013","unstructured":"Chaves de Souza, J. A. et al. SOCS3 expression correlates with severity of inflammation, expression of proinflammatory cytokines, and activation of STAT3 and p38 MAPK in LPS-induced inflammation in vivo. Mediators Inflamm. 2013, 650812 (2013).","journal-title":"Mediators Inflamm."},{"key":"478_CR186","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","volume":"8","author":"ME Bahar","year":"2023","unstructured":"Bahar, M. E., Kim, H. J. & Kim, D. R. Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct. Target Ther. 8, 455 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"478_CR187","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cellsig.2010.08.013","volume":"23","author":"H Lue","year":"2011","unstructured":"Lue, H., Dewor, M., Leng, L., Bucala, R. & Bernhagen, J. Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74. Cell Signal 23, 135\u2013144 (2011).","journal-title":"Cell Signal"},{"key":"478_CR188","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2021.105323","volume":"134","author":"H Kaneko","year":"2022","unstructured":"Kaneko, H. et al. Inhibition of c-Jun N-terminal kinase signaling promotes osteoblastic differentiation of periodontal ligament stem cells and induces regeneration of periodontal tissues. Arch. Oral. Biol. 134, 105323 (2022).","journal-title":"Arch. Oral. Biol."},{"key":"478_CR189","doi-asserted-by":"publisher","DOI":"10.4110\/in.2018.18.e8","volume":"18","author":"DS Amarasekara","year":"2018","unstructured":"Amarasekara, D. S. et al. Regulation of osteoclast differentiation by cytokine networks. Immune Netw. 18, e8 (2018).","journal-title":"Immune Netw."},{"key":"478_CR190","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.4161\/cc.6.11.4315","volume":"6","author":"E Perdiguero","year":"2007","unstructured":"Perdiguero, E., Ruiz-Bonilla, V., Serrano, A. L. & Munoz-Canoves, P. Genetic deficiency of p38alpha reveals its critical role in myoblast cell cycle exit: the p38alpha-JNK connection. Cell Cycle 6, 1298\u20131303 (2007).","journal-title":"Cell Cycle"},{"key":"478_CR191","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1167\/iovs.06-0642","volume":"47","author":"Z Wang","year":"2006","unstructured":"Wang, Z. et al. Phosphatase-mediated crosstalk control of ERK and p38 MAPK signaling in corneal epithelial cells. Investig. Ophthalmol. Vis. Sci. 47, 5267\u20135275 (2006).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"478_CR192","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1902\/jop.2007.070101","volume":"78","author":"JE Rogers","year":"2007","unstructured":"Rogers, J. E. et al. A p38 mitogen-activated protein kinase inhibitor arrests active alveolar bone loss in a rat periodontitis model. J. Periodontol. 78, 1992\u20131998 (2007).","journal-title":"J. Periodontol."},{"key":"478_CR193","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1124\/jpet.110.172395","volume":"336","author":"Q Li","year":"2011","unstructured":"Li, Q. et al. Silencing mitogen-activated protein kinase-activated protein kinase-2 arrests inflammatory bone loss. J. Pharm. Exp. Ther. 336, 633\u2013642 (2011).","journal-title":"J. Pharm. Exp. Ther."},{"key":"478_CR194","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1902\/jop.2016.160396","volume":"88","author":"L Jiang","year":"2017","unstructured":"Jiang, L. et al. The proteasome inhibitor bortezomib inhibits inflammatory response of periodontal ligament cells and ameliorates experimental periodontitis in rats. J. Periodontol. 88, 473\u2013483 (2017).","journal-title":"J. Periodontol."},{"key":"478_CR195","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1541714","volume":"16","author":"C Liu","year":"2025","unstructured":"Liu, C. et al. Research on the role and mechanism of the PI3K\/Akt\/mTOR signalling pathway in osteoporosis. Front. Endocrinol. 16, 1541714 (2025).","journal-title":"Front. Endocrinol."},{"key":"478_CR196","doi-asserted-by":"publisher","first-page":"12901","DOI":"10.1073\/pnas.1001499107","volume":"107","author":"H Kang","year":"2010","unstructured":"Kang, H., Chang, W., Hurley, M., Vignery, A. & Wu, D. Important roles of PI3Kgamma in osteoclastogenesis and bone homeostasis. Proc. Natl. Acad. Sci. USA 107, 12901\u201312906 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"478_CR197","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4049\/jimmunol.1101254","volume":"188","author":"JB Moon","year":"2012","unstructured":"Moon, J. B. et al. Akt induces osteoclast differentiation through regulating the GSK3beta\/NFATc1 signaling cascade. J. Immunol. 188, 163\u2013169 (2012).","journal-title":"J. Immunol."},{"key":"478_CR198","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S1097-2765(00)80232-4","volume":"4","author":"BR Wong","year":"1999","unstructured":"Wong, B. R. et al. TRANCE, a TNF family member, activates Akt\/PKB through a signaling complex involving TRAF6 and c-Src. Mol. Cell 4, 1041\u20131049 (1999).","journal-title":"Mol. Cell"},{"key":"478_CR199","doi-asserted-by":"publisher","unstructured":"Lv, H. et al. Kurarinone mitigates LPS-induced inflammatory osteolysis by inhibiting osteoclastogenesis through the reduction of ROS levels and suppression of the PI3K\/AKT signaling pathway. Inflammation https:\/\/doi.org\/10.1007\/s10753-025-02244-1 (2025).","DOI":"10.1007\/s10753-025-02244-1"},{"key":"478_CR200","doi-asserted-by":"publisher","first-page":"133","DOI":"10.5603\/fhc.101230","volume":"62","author":"Y Tang","year":"2024","unstructured":"Tang, Y., Pan, J., Guo, H. & Li, Q. Identification of an active fraction of Kangfuxin in the treatment of periodontitis in a rat model. Folia Histochem Cytobiol. 62, 133\u2013144 (2024).","journal-title":"Folia Histochem Cytobiol."},{"key":"478_CR201","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/jre.13252","volume":"59","author":"W Wang","year":"2024","unstructured":"Wang, W. et al. Capsaicin attenuates Porphyromonas gingivalis-suppressed osteogenesis of periodontal ligament stem cells via regulating mitochondrial function and activating PI3K\/AKT\/mTOR pathway. J. Periodontal Res. 59, 798\u2013811 (2024).","journal-title":"J. Periodontal Res."},{"key":"478_CR202","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.2147\/IJN.S510417","volume":"20","author":"C Yu","year":"2025","unstructured":"Yu, C. et al. Garlic-derived exosome-like nanovesicles: a promising natural nanotherapy for periodontitis via PHGDH\/PI3K\/AKT-mediated metabolic and inflammatory regulation. Int. J. Nanomed. 20, 5551\u20135572 (2025).","journal-title":"Int. J. Nanomed."},{"key":"478_CR203","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Wnt\/beta-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct. Target Ther. 7, 3 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"478_CR204","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/onc.2016.304","volume":"36","author":"T Zhan","year":"2017","unstructured":"Zhan, T., Rindtorff, N. & Boutros, M. Wnt signaling in cancer. Oncogene 36, 1461\u20131473 (2017).","journal-title":"Oncogene"},{"key":"478_CR205","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110935","volume":"133","author":"J Bao","year":"2021","unstructured":"Bao, J., Yang, Y., Xia, M., Sun, W. & Chen, L. Wnt signaling: an attractive target for periodontitis treatment. Biomed. Pharmacother. 133, 110935 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"478_CR206","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.biocel.2016.05.015","volume":"77","author":"P Duan","year":"2016","unstructured":"Duan, P. & Bonewald, L. F. The role of the wnt\/beta-catenin signaling pathway in formation and maintenance of bone and teeth. Int. J. Biochem. Cell Biol. 77, 23\u201329 (2016).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"478_CR207","doi-asserted-by":"publisher","first-page":"E478","DOI":"10.1073\/pnas.1409857112","volume":"112","author":"X Tu","year":"2015","unstructured":"Tu, X. et al. Osteocytes mediate the anabolic actions of canonical Wnt\/beta-catenin signaling in bone. Proc. Natl. Acad. Sci. USA 112, E478\u2013486 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"478_CR208","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.998244","volume":"13","author":"M Zhou","year":"2022","unstructured":"Zhou, M. & Graves, D. T. Impact of the host response and osteoblast lineage cells on periodontal disease. Front. Immunol. 13, 998244 (2022).","journal-title":"Front. Immunol."},{"key":"478_CR209","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jmb.2014.11.001","volume":"427","author":"H Nishi","year":"2015","unstructured":"Nishi, H., Demir, E. & Panchenko, A. R. Crosstalk between signaling pathways provided by single and multiple protein phosphorylation sites. J. Mol. Biol. 427, 511\u2013520 (2015).","journal-title":"J. Mol. Biol."},{"key":"478_CR210","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/cells14030226","volume":"14","author":"X Chu","year":"2025","unstructured":"Chu, X. et al. The role of senescence in experimental periodontitis at the causal level: an in vivo study. Cells 14, 226 (2025).","journal-title":"Cells"},{"key":"478_CR211","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.tibs.2014.04.004","volume":"39","author":"Y Xu","year":"2014","unstructured":"Xu, Y., Li, N., Xiang, R. & Sun, P. Emerging roles of the p38 MAPK and PI3K\/AKT\/mTOR pathways in oncogene-induced senescence. Trends Biochem. Sci. 39, 268\u2013276 (2014).","journal-title":"Trends Biochem. Sci."},{"key":"478_CR212","doi-asserted-by":"publisher","first-page":"5083","DOI":"10.1038\/onc.2010.252","volume":"29","author":"H Li","year":"2010","unstructured":"Li, H. et al. Transcriptional factor HBP1 targets P16(INK4A), upregulating its expression and consequently is involved in Ras-induced premature senescence. Oncogene 29, 5083\u20135094 (2010).","journal-title":"Oncogene"},{"key":"478_CR213","doi-asserted-by":"publisher","first-page":"481","DOI":"10.18632\/aging.100673","volume":"6","author":"A Borodkina","year":"2014","unstructured":"Borodkina, A., Shatrova, A., Abushik, P., Nikolsky, N. & Burova, E. Interaction between ROS dependent DNA damage, mitochondria and p38 MAPK underlies senescence of human adult stem cells. Aging 6, 481\u2013495 (2014).","journal-title":"Aging"},{"key":"478_CR214","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/emboj.2011.69","volume":"30","author":"A Freund","year":"2011","unstructured":"Freund, A., Patil, C. K. & Campisi, J. p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J. 30, 1536\u20131548 (2011).","journal-title":"EMBO J."},{"key":"478_CR215","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111549","volume":"127","author":"M Yin","year":"2025","unstructured":"Yin, M., Zheng, X. & Shi, L. Targeting p38 MAPK: a potential bridge between ER stress and age-related bone loss. Cell Signal 127, 111549 (2025).","journal-title":"Cell Signal"},{"key":"478_CR216","doi-asserted-by":"publisher","DOI":"10.1155\/bmri\/1716735","volume":"2024","author":"GE Oliveira","year":"2024","unstructured":"Oliveira, G. E. et al. Exploring the impact of biological agents on protecting against experimental periodontitis: a systematic review of animal-based studies. Biomed. Res. Int. 2024, 1716735 (2024).","journal-title":"Biomed. Res. Int."},{"key":"478_CR217","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5832009","volume":"2022","author":"ALR Pavanelli","year":"2022","unstructured":"Pavanelli, A. L. R. et al. Pharmacological therapies for the management of inflammatory bone resorption in periodontal disease: a review of preclinical studies. Biomed. Res. Int. 2022, 5832009 (2022).","journal-title":"Biomed. Res. Int."},{"key":"478_CR218","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1196\/annals.1346.042","volume":"1068","author":"BF Boyce","year":"2006","unstructured":"Boyce, B. F. et al. Future anti-catabolic therapeutic targets in bone disease. Ann. N. Y. Acad. Sci. 1068, 447\u2013457 (2006).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"478_CR219","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.781378","volume":"12","author":"B Yang","year":"2021","unstructured":"Yang, B., Pang, X., Li, Z., Chen, Z. & Wang, Y. Immunomodulation in the treatment of periodontitis: progress and perspectives. Front. Immunol. 12, 781378 (2021).","journal-title":"Front. Immunol."},{"key":"478_CR220","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41413-024-00356-2","volume":"12","author":"Y Wu","year":"2024","unstructured":"Wu, Y. et al. Bone targeted nano-drug and nano-delivery. Bone Res. 12, 51 (2024).","journal-title":"Bone Res."},{"key":"478_CR221","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3390\/ijms18071345","volume":"18","author":"M Stapleton","year":"2017","unstructured":"Stapleton, M. et al. Development of bone targeting drugs. Int. J. Mol. Sci. 18, 1345 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"478_CR222","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1902\/jop.2013.130225","volume":"85","author":"RS de Molon","year":"2014","unstructured":"de Molon, R. S. et al. Evaluation of the host response in various models of induced periodontal disease in mice. J. Periodontol. 85, 465\u2013477 (2014).","journal-title":"J. Periodontol."},{"key":"478_CR223","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s00784-015-1607-0","volume":"20","author":"RS de Molon","year":"2016","unstructured":"de Molon, R. S. et al. Long-term evaluation of oral gavage with periodontopathogens or ligature induction of experimental periodontal disease in mice. Clin. Oral. Investig. 20, 1203\u20131216 (2016).","journal-title":"Clin. Oral. Investig."},{"key":"478_CR224","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/jemt.23101","volume":"81","author":"RS de Molon","year":"2018","unstructured":"de Molon, R. S., Park, C. H., Jin, Q., Sugai, J. & Cirelli, J. A. Characterization of ligature-induced experimental periodontitis. Microsc Res. Tech. 81, 1412\u20131421 (2018).","journal-title":"Microsc Res. Tech."},{"key":"478_CR225","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/jicd.12018","volume":"4","author":"RS de Molon","year":"2013","unstructured":"de Molon, R. S., de Avila, E. D. & Cirelli, J. A. Host responses induced by different animal models of periodontal disease: a literature review. J. Investig. Clin. Dent. 4, 211\u2013218 (2013).","journal-title":"J. Investig. Clin. Dent."},{"key":"478_CR226","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1600-0757.2010.00355.x","volume":"54","author":"M Koide","year":"2010","unstructured":"Koide, M., Kinugawa, S., Takahashi, N. & Udagawa, N. Osteoclastic bone resorption induced by innate immune responses. Periodontol 2000 54, 235\u2013246 (2010).","journal-title":"Periodontol 2000"},{"key":"478_CR227","doi-asserted-by":"publisher","first-page":"5611","DOI":"10.3390\/ijms26125611","volume":"26","author":"BR Silva","year":"2025","unstructured":"Silva, B. R. et al. Establishing a dual murine model to explore the interactions between diabetes and periodontitis in mice. Int. J. Mol. Sci. 26, 5611 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"478_CR228","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/aps.2014.131","volume":"36","author":"L Zhen","year":"2015","unstructured":"Zhen, L., Fan, D. S., Zhang, Y., Cao, X. M. & Wang, L. M. Resveratrol ameliorates experimental periodontitis in diabetic mice through negative regulation of TLR4 signaling. Acta Pharm. Sin. 36, 221\u2013228 (2015).","journal-title":"Acta Pharm. Sin."},{"key":"478_CR229","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13005-018-0169-1","volume":"14","author":"CJ Xiao","year":"2018","unstructured":"Xiao, C. J., Yu, X. J., Xie, J. L., Liu, S. & Li, S. Protective effect and related mechanisms of curcumin in rat experimental periodontitis. Head. Face Med. 14, 12 (2018).","journal-title":"Head. Face Med."},{"key":"478_CR230","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1007\/s10753-017-0587-4","volume":"40","author":"MS Elburki","year":"2017","unstructured":"Elburki, M. S. et al. A chemically modified curcumin (CMC 2.24) inhibits nuclear factor kappaB activation and inflammatory bone loss in murine models of LPS-induced experimental periodontitis and diabetes-associated natural periodontitis. Inflammation 40, 1436\u20131449 (2017).","journal-title":"Inflammation"},{"key":"478_CR231","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.clim.2007.08.013","volume":"126","author":"M Wong","year":"2008","unstructured":"Wong, M. et al. TNFalpha blockade in human diseases: mechanisms and future directions. Clin. Immunol. 126, 121\u2013136 (2008).","journal-title":"Clin. Immunol."},{"key":"478_CR232","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12621","volume":"281","author":"CA Dinarello","year":"2018","unstructured":"Dinarello, C. A. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol. Rev. 281, 8\u201327 (2018).","journal-title":"Immunol. Rev."},{"key":"478_CR233","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1002\/art.11131","volume":"48","author":"KW McIntyre","year":"2003","unstructured":"McIntyre, K. W. et al. A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice. Arthritis Rheum. 48, 2652\u20132659 (2003).","journal-title":"Arthritis Rheum."},{"key":"478_CR234","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1124\/jpet.109.156018","volume":"331","author":"KM Gillooly","year":"2009","unstructured":"Gillooly, K. M. et al. Periodic, partial inhibition of IkappaB Kinase beta-mediated signaling yields therapeutic benefit in preclinical models of rheumatoid arthritis. J. Pharm. Exp. Ther. 331, 349\u2013360 (2009).","journal-title":"J. Pharm. Exp. Ther."},{"key":"478_CR235","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.3390\/ijms22073641","volume":"22","author":"YK Huang","year":"2021","unstructured":"Huang, Y. K. IL-8 as a potential therapeutic target for periodontitis and its inhibition by caffeic acid phenethyl ester in vitro. Int. J. Mol. Sci. 22, 3641 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"478_CR236","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1179007","volume":"14","author":"T Aoki","year":"2023","unstructured":"Aoki, T. et al. Inhibition of non-canonical NF-kappaB signaling suppresses periodontal inflammation and bone loss. Front. Immunol. 14, 1179007 (2023).","journal-title":"Front. Immunol."},{"key":"478_CR237","doi-asserted-by":"publisher","first-page":"10432","DOI":"10.1002\/jcp.27711","volume":"234","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. AZD8835 inhibits osteoclastogenesis and periodontitis-induced alveolar bone loss in rats. J. Cell Physiol. 234, 10432\u201310444 (2019).","journal-title":"J. Cell Physiol."},{"key":"478_CR238","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nm1054","volume":"10","author":"E Jimi","year":"2004","unstructured":"Jimi, E. et al. Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nat. Med. 10, 617\u2013624 (2004).","journal-title":"Nat. Med."},{"key":"478_CR239","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2023.119521","volume":"1870","author":"Z Zhang","year":"2023","unstructured":"Zhang, Z. et al. NAT10 regulates the LPS-induced inflammatory response via the NOX2-ROS-NF-kappaB pathway in macrophages. Biochim. Biophys. Acta Mol. Cell Res. 1870, 119521 (2023).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"478_CR240","doi-asserted-by":"publisher","first-page":"9637","DOI":"10.2147\/JIR.S490823","volume":"17","author":"Y Zhu","year":"2024","unstructured":"Zhu, Y., Qiao, S., Pang, Y., Wang, H. & Zhou, Y. Deferoxamine treatment effectively prevents periodontitis progression by reducing inflammation and osteoclastogenesis in experimental periodontitis rats. J. Inflamm. Res. 17, 9637\u20139650 (2024).","journal-title":"J. Inflamm. Res."},{"key":"478_CR241","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/jcpe.13282","volume":"47","author":"EA Cafferata","year":"2020","unstructured":"Cafferata, E. A. et al. Interleukin-35 inhibits alveolar bone resorption by modulating the Th17\/Treg imbalance during periodontitis. J. Clin. Periodontol. 47, 676\u2013688 (2020).","journal-title":"J. Clin. Periodontol."},{"key":"478_CR242","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2023.105629","volume":"147","author":"L Li","year":"2023","unstructured":"Li, L. et al. IL-37 alleviates alveolar bone resorption and inflammatory response through the NF-kappaB\/NLRP3 signaling pathway in male mice with periodontitis. Arch. Oral. Biol. 147, 105629 (2023).","journal-title":"Arch. Oral. Biol."},{"key":"478_CR243","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/omi.12335","volume":"36","author":"B Wang","year":"2021","unstructured":"Wang, B. et al. TPCA-1 negatively regulates inflammation mediated by NF-kappaB pathway in mouse chronic periodontitis model. Mol. Oral. Microbiol. 36, 192\u2013201 (2021).","journal-title":"Mol. Oral. Microbiol."},{"key":"478_CR244","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2021.106052","volume":"139","author":"J Wang","year":"2021","unstructured":"Wang, J. et al. Inhibition of nuclear factor kappa B inducing kinase suppresses inflammatory responses and the symptoms of chronic periodontitis in a mouse model. Int. J. Biochem. Cell Biol. 139, 106052 (2021).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"478_CR245","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1021\/acsptsci.1c00017","volume":"4","author":"S Girisa","year":"2021","unstructured":"Girisa, S. et al. From simple mouth cavities to complex oral mucosal disorders-curcuminoids as a promising therapeutic approach. ACS Pharm. Transl. Sci. 4, 647\u2013665 (2021).","journal-title":"ACS Pharm. Transl. Sci."},{"key":"478_CR246","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/jre.12238","volume":"50","author":"T Minagawa","year":"2015","unstructured":"Minagawa, T. et al. Resveratrol suppresses the inflammatory responses of human gingival epithelial cells in a SIRT1 independent manner. J. Periodontal Res. 50, 586\u2013593 (2015).","journal-title":"J. Periodontal Res."},{"key":"478_CR247","doi-asserted-by":"publisher","first-page":"4840","DOI":"10.1039\/D2TB00484D","volume":"10","author":"Y Tan","year":"2022","unstructured":"Tan, Y., Feng, J., Xiao, Y. & Bao, C. Grafting resveratrol onto mesoporous silica nanoparticles towards efficient sustainable immunoregulation and insulin resistance alleviation for diabetic periodontitis therapy. J. Mater. Chem. B 10, 4840\u20134855 (2022).","journal-title":"J. Mater. Chem. B"},{"key":"478_CR248","doi-asserted-by":"publisher","first-page":"7894","DOI":"10.1039\/D2NR06452A","volume":"15","author":"H Huangfu","year":"2023","unstructured":"Huangfu, H. et al. Facile engineering of resveratrol nanoparticles loaded with 20(S)-protopanaxadiol for the treatment of periodontitis by regulating the macrophage phenotype. Nanoscale 15, 7894\u20137908 (2023).","journal-title":"Nanoscale"},{"key":"478_CR249","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.actbio.2025.05.034","volume":"200","author":"Y Zhu","year":"2025","unstructured":"Zhu, Y. et al. A Chitosan-based hydrogel to modulate immune cells and promote periodontitis healing in the high-fat diet-induced periodontitis rat model. Acta Biomater. 200, 452\u2013463 (2025).","journal-title":"Acta Biomater."},{"key":"478_CR250","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3390\/dj13070309","volume":"9","author":"RS de Molon","year":"2025","unstructured":"de Molon, R. S. Therapeutic potential of tanshinones in osteolytic diseases: from molecular and cellular pathways to preclinical models. Dent. J. 9, 309 (2025).","journal-title":"Dent. J."},{"key":"478_CR251","doi-asserted-by":"publisher","unstructured":"Pavanelli, A. L. R. et al. Anti-inflammatory and antiresorptive activities of tanshinone-IIA mitigate alveolar bone destruction in mice with experimental periodontitis. J. Periodontol. https:\/\/doi.org\/10.1002\/JPER.24-0618 (2025).","DOI":"10.1002\/JPER.24-0618"},{"key":"478_CR252","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/JPER.20-0055","volume":"92","author":"EA Cafferata","year":"2021","unstructured":"Cafferata, E. A. et al. Boldine inhibits the alveolar bone resorption during ligature-induced periodontitis by modulating the Th17\/Treg imbalance. J. Periodontol. 92, 123\u2013136 (2021).","journal-title":"J. Periodontol."},{"key":"478_CR253","doi-asserted-by":"publisher","first-page":"11009","DOI":"10.1002\/jcp.27924","volume":"234","author":"H Liu","year":"2019","unstructured":"Liu, H. et al. Hesperetin suppresses RANKL-induced osteoclastogenesis and ameliorates lipopolysaccharide-induced bone loss. J. Cell Physiol. 234, 11009\u201311022 (2019).","journal-title":"J. Cell Physiol."},{"key":"478_CR254","doi-asserted-by":"publisher","first-page":"7100","DOI":"10.3390\/ijms23137100","volume":"23","author":"VP Goncalves","year":"2022","unstructured":"Goncalves, V. P. et al. Systemic dietary hesperidin modulation of osteoclastogenesis, bone homeostasis and periodontal disease in mice. Int. J. Mol. Sci 23, 7100 (2022).","journal-title":"Int. J. Mol. Sci"},{"key":"478_CR255","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1111\/odi.14712","volume":"30","author":"J Fu","year":"2024","unstructured":"Fu, J. et al. Lactobacillus rhamnosus inhibits osteoclast differentiation by suppressing the TLR2\/NF-kappaB pathway. Oral. Dis. 30, 2373\u20132386 (2024).","journal-title":"Oral. Dis."},{"key":"478_CR256","first-page":"663","volume":"2","author":"H Marotte","year":"2008","unstructured":"Marotte, H. & Miossec, P. Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFalpha therapy. Biologics 2, 663\u2013669 (2008).","journal-title":"Biologics"},{"key":"478_CR257","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1177\/1535370213520114","volume":"239","author":"DC Goncalves","year":"2014","unstructured":"Goncalves, D. C. et al. Infliximab attenuates inflammatory osteolysis in a model of periodontitis in Wistar rats. Exp. Biol. Med. 239, 442\u2013453 (2014).","journal-title":"Exp. Biol. Med."},{"key":"478_CR258","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nrd3800","volume":"11","author":"CA Dinarello","year":"2012","unstructured":"Dinarello, C. A., Simon, A. & van der Meer, J. W. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat. Rev. Drug Discov. 11, 633\u2013652 (2012).","journal-title":"Nat. Rev. Drug Discov."},{"key":"478_CR259","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13075-019-1952-5","volume":"21","author":"F Wang","year":"2019","unstructured":"Wang, F. et al. IL-1beta receptor antagonist (IL-1Ra) combined with autophagy inducer (TAT-Beclin1) is an effective alternative for attenuating extracellular matrix degradation in rat and human osteoarthritis chondrocytes. Arthritis Res. Ther. 21, 171 (2019).","journal-title":"Arthritis Res. Ther."},{"key":"478_CR260","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.imlet.2016.02.011","volume":"172","author":"SY Lee","year":"2016","unstructured":"Lee, S. Y. et al. IL-1 receptor antagonist (IL-1Ra)-Fc ameliorate autoimmune arthritis by regulation of the Th17 cells\/Treg balance and arthrogenic cytokine activation. Immunol. Lett. 172, 56\u201366 (2016).","journal-title":"Immunol. Lett."},{"key":"478_CR261","doi-asserted-by":"publisher","first-page":"13939","DOI":"10.3390\/ijms232213939","volume":"23","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Treatment of periodontal inflammation in diabetic rats with IL-1ra thermosensitive hydrogel. Int. J. Mol. Sci. 23, 13939 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"478_CR262","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/cei\/uxad064","volume":"213","author":"T Hashimoto","year":"2023","unstructured":"Hashimoto, T. et al. Tocilizumab suppresses NF-kappa B activation via toll-like receptor 9 signaling by reducing cell-free DNA in rheumatoid arthritis. Clin. Exp. Immunol. 213, 209\u2013220 (2023).","journal-title":"Clin. Exp. Immunol."},{"key":"478_CR263","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/JPER.20-0455","volume":"92","author":"GH Apolinario Vieira","year":"2021","unstructured":"Apolinario Vieira, G. H. et al. Specific inhibition of IL-6 receptor attenuates inflammatory bone loss in experimental periodontitis. J. Periodontol. 92, 1460\u20131469 (2021).","journal-title":"J. Periodontol."},{"key":"478_CR264","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1210\/en.2012-1928","volume":"154","author":"M Koide","year":"2013","unstructured":"Koide, M. et al. Osteoprotegerin-deficient male mice as a model for severe alveolar bone loss: comparison with RANKL-overexpressing transgenic male mice. Endocrinology 154, 773\u2013782 (2013).","journal-title":"Endocrinology"},{"key":"478_CR265","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings, S. R. et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N. Engl. J. Med. 361, 756\u2013765 (2009).","journal-title":"N. Engl. J. Med."},{"key":"478_CR266","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/j.1600-051X.2011.01780.x","volume":"38","author":"H Yuan","year":"2011","unstructured":"Yuan, H., Gupte, R., Zelkha, S. & Amar, S. Receptor activator of nuclear factor kappa B ligand antagonists inhibit tissue inflammation and bone loss in experimental periodontitis. J. Clin. Periodontol. 38, 1029\u20131036 (2011).","journal-title":"J. Clin. Periodontol."},{"key":"478_CR267","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bone.2014.07.027","volume":"68","author":"RS de Molon","year":"2014","unstructured":"de Molon, R. S. et al. Spontaneous osteonecrosis of the jaws in the maxilla of mice on antiresorptive treatment: a novel ONJ mouse model. Bone 68, 11\u201319 (2014).","journal-title":"Bone"},{"key":"478_CR268","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/jbmr.2490","volume":"30","author":"RS de Molon","year":"2015","unstructured":"de Molon, R. S. et al. OPG-Fc but not zoledronic acid discontinuation reverses osteonecrosis of the jaws (ONJ) in mice. J. Bone Miner. Res 30, 1627\u20131640 (2015).","journal-title":"J. Bone Miner. Res"},{"key":"478_CR269","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.bone.2016.06.011","volume":"90","author":"A Soundia","year":"2016","unstructured":"Soundia, A. et al. Osteonecrosis of the jaws (ONJ) in mice after extraction of teeth with periradicular disease. Bone 90, 133\u2013141 (2016).","journal-title":"Bone"},{"key":"478_CR270","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1002\/jbmr.2827","volume":"31","author":"RS de Molon","year":"2016","unstructured":"de Molon, R. S. et al. Rheumatoid arthritis exacerbates the severity of osteonecrosis of the jaws (ONJ) in mice. a randomized, prospective, controlled animal study. J. Bone Miner. Res. 31, 1596\u20131607 (2016).","journal-title":"J. Bone Miner. Res."},{"key":"478_CR271","doi-asserted-by":"publisher","first-page":"5441","DOI":"10.1210\/en.2003-0717","volume":"144","author":"M Nakamura","year":"2003","unstructured":"Nakamura, M. et al. Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption. Endocrinology 144, 5441\u20135449 (2003).","journal-title":"Endocrinology"},{"key":"478_CR272","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1902\/jop.2007.070073","volume":"78","author":"Q Jin","year":"2007","unstructured":"Jin, Q. et al. RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. J. Periodontol. 78, 1300\u20131308 (2007).","journal-title":"J. Periodontol."},{"key":"478_CR273","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s00198-021-05871-0","volume":"32","author":"A Hamar","year":"2021","unstructured":"Hamar, A. et al. Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis. Osteoporos. Int. 32, 1621\u20131629 (2021).","journal-title":"Osteoporos. Int."},{"key":"478_CR274","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s41927-019-0062-y","volume":"3","author":"T Kobayashi","year":"2019","unstructured":"Kobayashi, T., Ito, S., Murasawa, A., Ishikawa, H. & Yoshie, H. Effects of tofacitinib on the clinical features of periodontitis in patients with rheumatoid arthritis: two case reports. BMC Rheumatol. 3, 13 (2019).","journal-title":"BMC Rheumatol."},{"key":"478_CR275","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1002\/art.37691","volume":"64","author":"A Yarilina","year":"2012","unstructured":"Yarilina, A., Xu, K., Chan, C. & Ivashkiv, L. B. Regulation of inflammatory responses in tumor necrosis factor-activated and rheumatoid arthritis synovial macrophages by JAK inhibitors. Arthritis Rheum. 64, 3856\u20133866 (2012).","journal-title":"Arthritis Rheum."},{"key":"478_CR276","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.intimp.2018.03.021","volume":"58","author":"CH Li","year":"2018","unstructured":"Li, C. H. et al. Stattic inhibits RANKL-mediated osteoclastogenesis by suppressing activation of STAT3 and NF-kappaB pathways. Int. Immunopharmacol. 58, 136\u2013144 (2018).","journal-title":"Int. Immunopharmacol."},{"key":"478_CR277","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/308943","volume":"2012","author":"Q Li","year":"2012","unstructured":"Li, Q., Valerio, M. S. & Kirkwood, K. L. MAPK usage in periodontal disease progression. J. Signal Transduct. 2012, 308943 (2012).","journal-title":"J. Signal Transduct."},{"key":"478_CR278","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2020.104992","volume":"122","author":"L Gu","year":"2021","unstructured":"Gu, L., Ke, Y., Gan, J. & Li, X. Berberine suppresses bone loss and inflammation in ligature-induced periodontitis through promotion of the G protein-coupled estrogen receptor-mediated inactivation of the p38MAPK\/NF-kappaB pathway. Arch. Oral. Biol. 122, 104992 (2021).","journal-title":"Arch. Oral. Biol."},{"key":"478_CR279","doi-asserted-by":"publisher","first-page":"6364","DOI":"10.3390\/ijms24076364","volume":"24","author":"C Wang","year":"2023","unstructured":"Wang, C. et al. Role of berberine thermosensitive hydrogel in periodontitis via PI3K\/AKT pathway in vitro. Int. J. Mol. Sci. 24, 6364 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"478_CR280","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112720","volume":"139","author":"B Zhao","year":"2024","unstructured":"Zhao, B. et al. Eupatilin suppresses osteoclastogenesis and periodontal bone loss by inhibiting the MAPKs\/Siglec-15 pathway. Int. Immunopharmacol. 139, 112720 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"478_CR281","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/jre.13154","volume":"58","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. The effect of the Litcubanine A on the treatment of murine experimental periodontitis by inhibiting monocyte-macrophage chemotaxis and osteoclast differentiation. J. Periodontal Res. 58, 948\u2013958 (2023).","journal-title":"J. Periodontal Res."},{"key":"478_CR282","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.3390\/antiox13111332","volume":"13","author":"J Yang","year":"2024","unstructured":"Yang, J. et al. The effect of the root bark of Lycium chinense (Lycii Radicis Cortex) on experimental periodontitis and alveolar bone loss in Sprague-Dawley rats. Antioxidants 13, 1332 (2024).","journal-title":"Antioxidants"},{"key":"478_CR283","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1021\/acsptsci.3c00315","volume":"7","author":"JA Kim","year":"2024","unstructured":"Kim, J. A. et al. Napyradiomycin B4 suppresses RANKL-induced osteoclastogenesis and prevents alveolar bone destruction in experimental periodontitis. ACS Pharm. Transl. Sci. 7, 1023\u20131031 (2024).","journal-title":"ACS Pharm. Transl. Sci."},{"key":"478_CR284","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115392","volume":"166","author":"CL Liu","year":"2023","unstructured":"Liu, C. L. et al. Ugonin L inhibits osteoclast formation and promotes osteoclast apoptosis by inhibiting the MAPK and NF-kappaB pathways. Biomed. Pharmacother. 166, 115392 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"478_CR285","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.123024","volume":"316","author":"F Shuai","year":"2025","unstructured":"Shuai, F. et al. A nucleoside-based supramolecular hydrogel integrating localized self-delivery and immunomodulation for periodontitis treatment. Biomaterials 316, 123024 (2025).","journal-title":"Biomaterials"},{"key":"478_CR286","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1111\/odi.14352","volume":"29","author":"M Sun","year":"2023","unstructured":"Sun, M. et al. Ginsenoside Rb3 inhibits osteoclastogenesis via ERK\/NF-kappaB signaling pathway in vitro and in vivo. Oral. Dis. 29, 3460\u20133471 (2023).","journal-title":"Oral. Dis."},{"key":"478_CR287","doi-asserted-by":"publisher","first-page":"23013","DOI":"10.1039\/D0NR05551D","volume":"12","author":"Z Wang","year":"2020","unstructured":"Wang, Z., Zhan, C., Zeng, F. & Wu, S. A biopolymer-based and inflammation-responsive nanodrug for rheumatoid arthritis treatment via inhibiting JAK-STAT and JNK signalling pathways. Nanoscale 12, 23013\u201323027 (2020).","journal-title":"Nanoscale"},{"key":"478_CR288","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1172\/JCI12466","volume":"108","author":"Z Han","year":"2001","unstructured":"Han, Z. et al. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J. Clin. Invest. 108, 73\u201381 (2001).","journal-title":"J. Clin. Invest."},{"key":"478_CR289","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13651","volume":"57","author":"Y Sun","year":"2024","unstructured":"Sun, Y. et al. Intermittent hyperglycaemia induces macrophage dysfunction by extracellular regulated protein kinase-dependent PKM2 translocation in periodontitis. Cell Prolif. 57, e13651 (2024).","journal-title":"Cell Prolif."},{"key":"478_CR290","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.3390\/ijms22041915","volume":"22","author":"HJ Ihn","year":"2021","unstructured":"Ihn, H. J. et al. PF-3845, a fatty acid amide hydrolase inhibitor, directly suppresses osteoclastogenesis through ERK and NF-kappaB pathways in vitro and alveolar bone loss in vivo. Int. J. Mol. Sci. 22, 1915 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"478_CR291","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.2174\/1568026054985939","volume":"5","author":"DM Goldstein","year":"2005","unstructured":"Goldstein, D. M. & Gabriel, T. Pathway to the clinic: inhibition of P38 MAP kinase. A review of ten chemotypes selected for development. Curr. Top. Med. Chem. 5, 1017\u20131029 (2005).","journal-title":"Curr. Top. Med. Chem."},{"key":"478_CR292","first-page":"566","volume":"4","author":"C Pargellis","year":"2003","unstructured":"Pargellis, C. & Regan, J. Inhibitors of p38 mitogen-activated protein kinase for the treatment of rheumatoid arthritis. Curr. Opin. Investig. Drugs 4, 566\u2013571 (2003).","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"478_CR293","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1177\/154405910708600903","volume":"86","author":"CS Patil","year":"2007","unstructured":"Patil, C. S. & Kirkwood, K. L. p38 MAPK signaling in oral-related diseases. J. Dent. Res. 86, 812\u2013825 (2007).","journal-title":"J. Dent. Res."},{"key":"478_CR294","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156733","volume":"141","author":"J Cao","year":"2025","unstructured":"Cao, J. et al. Kaempferol combats the osteogenic differentiation damage of periodontal ligament stem cells in periodontitis via regulating EphrinB2-mediated PI3K\/Akt and P38 pathways. Phytomedicine 141, 156733 (2025).","journal-title":"Phytomedicine"},{"key":"478_CR295","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/JPER.24-0405","volume":"96","author":"H Mu","year":"2025","unstructured":"Mu, H. et al. Inhibition of fibulin-3 ameliorates periodontal inflammation through reducing M1 macrophage polarization via EGFR\/PI3K\/AKT pathway. J. Periodontol. 96, 440\u2013454 (2025).","journal-title":"J. Periodontol."},{"key":"478_CR296","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1600-051X.1984.tb01305.x","volume":"11","author":"SS Socransky","year":"1984","unstructured":"Socransky, S. S., Haffajee, A. D., Goodson, J. M. & Lindhe, J. New concepts of destructive periodontal disease. J. Clin. Periodontol. 11, 21\u201332 (1984).","journal-title":"J. Clin. Periodontol."},{"key":"478_CR297","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/j.1600-051X.1982.tb02108.x","volume":"9","author":"JM Goodson","year":"1982","unstructured":"Goodson, J. M., Tanner, A. C., Haffajee, A. D., Sornberger, G. C. & Socransky, S. S. Patterns of progression and regression of advanced destructive periodontal disease. J. Clin. Periodontol. 9, 472\u2013481 (1982).","journal-title":"J. Clin. Periodontol."},{"key":"478_CR298","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1600-051X.2007.01172.x","volume":"35","author":"DT Graves","year":"2008","unstructured":"Graves, D. T., Fine, D., Teng, Y. T., Van Dyke, T. E. & Hajishengallis, G. The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J. Clin. Periodontol. 35, 89\u2013105 (2008).","journal-title":"J. Clin. Periodontol."},{"key":"478_CR299","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1177\/0022034511399908","volume":"90","author":"JS Kinney","year":"2011","unstructured":"Kinney, J. S. et al. Saliva\/pathogen biomarker signatures and periodontal disease progression. J. Dent. Res. 90, 752\u2013758 (2011).","journal-title":"J. Dent. Res."},{"key":"478_CR300","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1902\/jop.2009.080480","volume":"80","author":"CA Ramseier","year":"2009","unstructured":"Ramseier, C. A. et al. Identification of pathogen and host-response markers correlated with periodontal disease. J. Periodontol. 80, 436\u2013446 (2009).","journal-title":"J. Periodontol."},{"key":"478_CR301","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2025.123726","volume":"363","author":"B Yilmaz","year":"2025","unstructured":"Yilmaz, B. et al. Dual-drug carboxymethyl chitosan hydrogel: development, characterization, and in vitro evaluation for periodontal therapy. Carbohydr. Polym. 363, 123726 (2025).","journal-title":"Carbohydr. Polym."},{"key":"478_CR302","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.101855","volume":"32","author":"B Yin","year":"2025","unstructured":"Yin, B. et al. Smart injectable hydrogels for periodontal regeneration: Recent advancements in biomaterials and biofabrication strategies. Mater. Today Bio 32, 101855 (2025).","journal-title":"Mater. Today Bio"},{"key":"478_CR303","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3390\/biom15060903","volume":"15","author":"M Nakajima","year":"2025","unstructured":"Nakajima, M. et al. Advances in local drug delivery for periodontal treatment: present strategies and future directions. Biomolecules 15, 903 (2025).","journal-title":"Biomolecules"},{"key":"478_CR304","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3390\/molecules30040807","volume":"30","author":"NT Hashim","year":"2025","unstructured":"Hashim, N. T. et al. New insights in natural bioactive compounds for periodontal disease: advanced molecular mechanisms and therapeutic potential. Molecules 30, 807 (2025).","journal-title":"Molecules"},{"key":"478_CR305","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1226907","volume":"11","author":"N Lopez-Valverde","year":"2023","unstructured":"Lopez-Valverde, N. et al. Antioxidant, anti-inflammatory and antimicrobial activity of natural products in periodontal disease: a comprehensive review. Front. Bioeng. Biotechnol. 11, 1226907 (2023).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"478_CR306","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s10787-024-01631-8","volume":"33","author":"MA Anwar","year":"2025","unstructured":"Anwar, M. A. et al. Herbal remedies for oral and dental health: a comprehensive review of their multifaceted mechanisms including antimicrobial, anti-inflammatory, and antioxidant pathways. Inflammopharmacology 33, 1085\u20131160 (2025).","journal-title":"Inflammopharmacology"},{"key":"478_CR307","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.3390\/molecules29133044","volume":"29","author":"NT Hashim","year":"2024","unstructured":"Hashim, N. T. et al. Natural bioactive compounds in the management of periodontal diseases: a comprehensive review. Molecules 29, 3044 (2024).","journal-title":"Molecules"}],"container-title":["Bone Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41413-025-00478-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41413-025-00478-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41413-025-00478-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T22:03:19Z","timestamp":1767477799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41413-025-00478-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":307,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["478"],"URL":"https:\/\/doi.org\/10.1038\/s41413-025-00478-1","relation":{},"ISSN":["2095-6231"],"issn-type":[{"value":"2095-6231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}